Contact

All Stories

  1. The Role of Unmethylated 5′-C-Phosphate-G-3′ (CpG) Motifs in Mitochondrial and Bacterial DNA in the Pathogenesis of Alzheimer’s Disease

    Article • Journal of Dementia and Alzheimer s Disease, February 2026, MDPI AG

    Professor George Perry

  2. Amyloid-β and phosphorylated-tau accumulation in retrosplenial cortex of young Alzheimer's disease model: Impact on network activity

    Article • Journal of Alzheimer’s Disease, February 2026, SAGE Publications

    Professor George Perry

  3. Recommendations for reporting findings from analyses using artificial intelligence and machine learning in the Journal of Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, January 2026, SAGE Publications

    Professor Paula I. Moreira, Professor George Perry

  4. The Amyloid Cascade Hypothesis

    Article • American Journal Of Pathology, November 2025, Elsevier

    Professor George Perry

  5. Conventional and Emerging Drug Targeting Sites in Alzheimer’s Disease and the Role of Translational Informatics in its Diagnosis and Management

    Article • Current Neuropharmacology, October 2025, Bentham Science Publishers

    Professor George Perry

  6. Is US residence a risk factor for Alzheimer's disease?

    Article • Journal of Alzheimer’s Disease, September 2025, SAGE Publications

    Professor George Perry

  7. Potential Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Diabetes and High Risk for Dementia

    Article • Annals of Internal Medicine, September 2025, American College of Physicians

    Professor George Perry

  8. Hyperphosphorylated Tau Induces Cortical Hypoexcitability in Transgenic Mouse Models: A Meta-Analysis

    Article • Journal of Integrative Neuroscience, August 2025, IMR Press

    Professor George Perry

  9. Living the examined life Ninety-Nine Lessons in Critical Thinking by Robert FriedlandP.Oxford University Press, 2025, 285 pp.

    Article • Journal of Alzheimer’s Disease, July 2025, SAGE Publications

    Professor George Perry

  10. Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data

    Article • Journal of Alzheimer’s Disease, June 2025, SAGE Publications

    Professor George Perry

  11. Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study

    Article • Journal of Alzheimer’s Disease, June 2025, SAGE Publications

    Professor George Perry

  12. Assessment of X Chromosome Centromere Instability in Alzheimer’s Disease: A Quantitative FISH Approach

    Article • Current Issues in Molecular Biology, June 2025, MDPI AG

    Dijana Topalovic, Professor George Perry

  13. Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease Progression, Biomarkers, and Amyloid Deposition

    Article • Neurology, February 2025, Wolters Kluwer Health

    Professor George Perry

  14. Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein Aggregates

    Article • ACS Omega, February 2025, American Chemical Society (ACS)

    Professor George Perry

  15. In data we trust. Book review: “Piller Charles. Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s” PillerCharles (2025). Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s. One...

    Article • Journal of Alzheimer’s Disease, February 2025, SAGE Publications

    Professor George Perry

  16. Exploring nutritional supplement use for countering respiratory tract infections through an X (formerly Twitter)-based survey

    Article • Current Research in Biotechnology, January 2025, Elsevier

    Dr Hemanth kumar Boyina , Prof. Tomasz M. Karpiński, Prof. Antoni Sureda, Dr Javier Echeverría, Mr SHRAVAN PASWAN, Professor George Perry, Prof.Dr. Emad M. Abdallah

  17. Progesterone induction of tau phosphorylation during the differentiation of human embryonic stem cells into neuroectodermal rosettes

    Article • Journal of Alzheimer s Disease Reports, January 2025, SAGE Publications

    Professor George Perry

  18. Assessment of X Chromosome Centromere Instability in Alzheimer’s Disease: A Quantitative FISH Approach

    Article • December 2024, MDPI AG

    Dijana Topalovic, Professor George Perry

  19. Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US

    Article • Alzheimer s & Dementia, October 2024, Wiley

    Professor George Perry

  20. Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics

    Article • ACS Chemical Neuroscience, October 2024, American Chemical Society (ACS)

    Professor George Perry

  21. Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, September 2024, IOS Press

    Professor George Perry

  22. Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?

    Article • Journal of Alzheimer’s Disease, August 2024, IOS Press

    Sónia Correia, Professor Paula I. Moreira, Professor George Perry

  23. Central role of brain regulatory T cells in the inflammatory cascade in Alzheimer’s disease

    Article • Proceedings of the National Academy of Sciences, July 2024, Proceedings of the National Academy of Sciences

    Professor George Perry

  24. JAD’s Glorious 100 Volumes

    Article • Journal of Alzheimer’s Disease, July 2024, IOS Press

    Professor George Perry

  25. Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?

    Article • International Journal of Molecular Sciences, March 2024, MDPI AG

    Professor George Perry

  26. Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues

    Article • ACS Chemical Neuroscience, March 2024, American Chemical Society (ACS)

    Professor George Perry

  27. Fabrication and Characterization of Quad-Component Bioinspired Hydrogels to Model Elevated Fibrin Levels in Central Nervous Tissue Scaffolds

    Article • Gels, March 2024, MDPI AG

    Professor George Perry

  28. Living Up to the Promise of Preventing Dementia

    Article • Journal of Alzheimer’s Disease, March 2024, IOS Press

    Professor George Perry

  29. Letter to the Editor: First Experiences with Amyloid-Related Imaging Abnormalities – Yet without Imaging that Can Rule Out Cerebral Injury or Monitor Efficacy of Recommended Management

    Article • The Journal of Prevention of Alzheimer s Disease, January 2024, SERDI

    Professor George Perry

  30. Revision of Alzheimer’s diagnostic criteria or relocation of the Potemkin village

    Article • Ageing Research Reviews, January 2024, Elsevier

    Professor George Perry

  31. Association of COVID-19 with Risk and Progression of Alzheimer’s Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects

    Article • Journal of Alzheimer’s Disease, December 2023, IOS Press

    Professor George Perry

  32. Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation

    Article • ACS Chemical Neuroscience, October 2023, American Chemical Society (ACS)

    Professor George Perry

  33. MicroRNA networks linked with BRCA1/2, PTEN, and common genes for Alzheimer's disease and breast cancer share highly enriched pathways that may unravel targets for the AD/BC comorbidity treatment

    Article • Computational Biology and Chemistry, October 2023, Elsevier

    Professor George Perry

  34. Slowing the Clock of Life

    Article • Journal of Alzheimer’s Disease, September 2023, IOS Press

    Professor George Perry

  35. Passive Alzheimer’s immunotherapy: A promising or uncertain option?

    Article • Ageing Research Reviews, September 2023, Elsevier

    Professor George Perry

  36. Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease

    Article • Antioxidants, August 2023, MDPI AG

    Professor George Perry

  37. Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases

    Article • International Journal of Molecular Sciences, August 2023, MDPI AG

    Professor George Perry

  38. The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes

    Article • Journal of Alzheimer’s Disease, July 2023, IOS Press

    Professor George Perry

  39. Memory, Sleep, and Tau Function

    Article • Journal of Alzheimer’s Disease, July 2023, IOS Press

    Professor George Perry

  40. FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls

    Article • Diagnostics, July 2023, MDPI AG

    Professor George Perry

  41. Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease

    Article • Alzheimer s & Dementia, June 2023, Wiley

    Professor George Perry

  42. The amyloid-β pathway in Alzheimer's disease: a plain language summary

    Article • Neurodegenerative Disease Management, June 2023, Future Medicine

    Professor George Perry

  43. The retina-brain axis and diabetic retinopathy

    Article • European Journal of Ophthalmology, May 2023, SAGE Publications

    Professor George Perry, Dr Moein Ebrahimi

  44. Universal research index: An inclusive metric to quantify scientific research output

    Article • The Journal of Academic Librarianship, May 2023, Elsevier

    Professor George Perry, Professor Amir H Gandomi, Dr. Bolajoko O. Olusanya

  45. Playing Russian Roulette with Alzheimer’s Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?

    Article • Journal of Alzheimer’s Disease, April 2023, IOS Press

    Professor George Perry

  46. Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain

    Article • Acta Neuropathologica Communications, March 2023, Springer Science + Business Media

    Professor George Perry

  47. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis

    Article • PLOS One, March 2023, PLOS

    Professor George Perry

  48. Alzheimer’s Disease: Not Just for the Aged?

    Article • Journal of Alzheimer’s Disease, January 2023, IOS Press

    Professor George Perry

  49. Beyond the Clouds: B.R. Brinkley (1936-2020)

    Article • Journal of Alzheimer’s Disease, January 2023, IOS Press

    Professor George Perry

  50. The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis

    Article • Phytomedicine, January 2023, Elsevier

    Dr Amr El-Demerdash, Professor George Perry, Prof. Antoni Sureda, Dr Smith B. Babiaka, Humboldt Fellow, Prof. Tomasz M. Karpiński, Dr Hemanth kumar Boyina , Hitesh Chopra, Jesus Simal-Gandara, Dr Javier Echeverría, Mr SHRAVAN PASWAN

  51. The Teflon hypothesis

    Article • Brain Communications, January 2023, Oxford University Press (OUP)

    Professor George Perry

  52. Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing

    Article • iScience, January 2023, Elsevier

    Professor George Perry

  53. Natural Product Co-Metabolism and the Microbiota–Gut–Brain Axis in Age-Related Diseases

    Article • Life, December 2022, MDPI AG

    Professor George Perry

  54. MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?

    Article • American Journal of Neuroradiology, December 2022, American Society of Neuroradiology (ASNR)

    Professor George Perry

  55. Retinal neurodegeneration in euglycemic hyperinsulinemia, prediabetes, and diabetes

    Article • Ophthalmic Research, December 2022, Karger Publishers

    Dr Moein Ebrahimi, Professor George Perry

  56. Mouse and Human Tau Expression in Different Brain Areas

    Article • Journal of Alzheimer s Disease Reports, November 2022, IOS Press

    Professor George Perry

  57. Therapeutic Antiaging Strategies

    Article • Biomedicines, October 2022, MDPI AG

    Professor George Perry

  58. Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia

    Article • American Journal Of Pathology, October 2022, Elsevier

    Professor George Perry

  59. Making the Case for Accelerated Withdrawal of Aducanumab

    Article • Journal of Alzheimer’s Disease, May 2022, IOS Press

    Professor George Perry

  60. Hyperphosphorylated Tau Relates to Improved Cognitive Performance and Reduced Hippocampal Excitability in the Young rTg4510 Mouse Model of Tauopathy

    Article • Journal of Alzheimer’s Disease, May 2022, IOS Press

    Professor George Perry

  61. Hypoxic Preconditioning Averts Sporadic Alzheimer's Disease-Like Phenotype in Rats: A Focus on Mitochondria

    Article • Antioxidants & Redox Signaling, May 2022, Mary Ann Liebert Inc

    Professor Paula I. Moreira, Professor George Perry

  62. Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

    Article • Journal of Alzheimer’s Disease, May 2022, IOS Press

    J. Wesson Ashford, Professor George Perry

  63. Multi-Task Graph Neural Network For Alzheimer’s Disease Drug Repurposing Using Knowledge Graph And Multi-Level Evidence

    Article • February 2022, Research Square

    Professor George Perry

  64. Optogenetics: implications for Alzheimer’s disease research and therapy

    Article • Molecular Brain, February 2022, Springer Science + Business Media

    Professor George Perry

  65. Editorial: Oxidative Stress Revisited—Major Role in Vascular Diseases, Volume II

    Article • Frontiers in Physiology, January 2022, Frontiers

    Professor George Perry

  66. SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer’s Disease and Other Brain Disorders

    Article • Journal of Alzheimer’s Disease, January 2022, IOS Press

    pravat mandal, Professor George Perry

  67. Conformation- and phosphorylation-dependent electron tunnelling across self-assembled monolayers of tau peptides

    Article • Journal of Colloid and Interface Science, January 2022, Elsevier

    Professor George Perry

  68. Alzheimer’s Disease Pharmacology

    Article • January 2022, Elsevier

    Professor George Perry

  69. Functional study in the young rTg4510 mouse model of tauopathy

    Article • Alzheimer s & Dementia, December 2021, Wiley

    Professor George Perry

  70. American Dementia: Brain Health in an Unhealthy Society by Daniel R. George and Peter J. Whitehouse, Johns Hopkins Press, 2021, 390 pp.

    Article • Journal of Alzheimer’s Disease, September 2021, IOS Press

    Professor George Perry

  71. The Amyloid-β Pathway in Alzheimer’s Disease

    Article • Molecular Psychiatry, August 2021, Springer Science + Business Media

    Professor George Perry, Professor Michele Vendruscolo

  72. Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease

    Article • Neurobiology of Disease, August 2021, Elsevier

    Professor George Perry

  73. Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence

    Article • Ageing Research Reviews, August 2021, Elsevier

    Professor George Perry

  74. Community Engagement Practices at Research Centers in U.S. Minority Institutions: Priority Populations and Innovative Approaches to Advancing Health Disparities Research

    Article • International Journal of Environmental Research and Public Health, June 2021, MDPI AG

    Professor George Perry

  75. Oxidative Stress Signaling in Blast TBI-Induced Tau Phosphorylation

    Article • Antioxidants, June 2021, MDPI AG

    Professor George Perry

  76. Biogenic metallic elements in the human brain?

    Article • Science Advances, June 2021, American Association for the Advancement of Science

    Professor George Perry

  77. Challenges and Strategies of Successful Mentoring: The Perspective of LEADS Scholars and Mentors from Minority Serving Institutions

    Article • International Journal of Environmental Research and Public Health, June 2021, MDPI AG

    Professor George Perry

  78. Reactive Oxygen Species and Their Impact in Neurodegenerative Diseases: Literature Landscape Analysis

    Article • Antioxidants & Redox Signaling, February 2021, Mary Ann Liebert Inc

    Professor George Perry

  79. MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness

    Article • The American Journal of Medicine, February 2021, Elsevier

    Professor George Perry, Dr. Christopher J. Wheeler

  80. Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy

    Article • Seminars in Cancer Biology, February 2021, Elsevier

    Professor George Perry

  81. Corrigendum to “Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer’s Disease”

    Article • Oxidative Medicine and Cellular Longevity, January 2021, Hindawi Publishing Corporation

    Professor George Perry

  82. Alzheimer’s and Consciousness: How Much Subjectivity Is Objective?

    Article • Neuroscience Insights, January 2021, SAGE Publications

    Professor George Perry

  83. A brief guide to the science and art of writing manuscripts in biomedicine

    Article • Journal of Translational Medicine, November 2020, Springer Science + Business Media

    Professor George Perry

  84. The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies

    Article • Journal of Clinical Medicine, August 2020, MDPI AG

    Professor George Perry

  85. Decreased salivary lactoferrin levels are specific to Alzheimer's disease

    Article • EBioMedicine, July 2020, Elsevier

    Prof HECTOR BUENO, Professor George Perry

  86. Alzheimer’s Disease Patients in the Crosshairs of COVID-19

    Article • Journal of Alzheimer’s Disease, June 2020, IOS Press

    Professor George Perry

  87. Role of antioxidants and a nutrient rich diet in Alzheimer's disease

    Article • Open Biology, June 2020, Royal Society Publishing

    Professor George Perry

  88. Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances

    Article • Molecular Neurodegeneration, May 2020, Springer Science + Business Media

    Professor George Perry

  89. The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases

    Article • Microorganisms, May 2020, MDPI AG

    Professor George Perry

  90. The Microbiota–Gut–Brain Axis–Heart Shunt Part II: Prosaic Foods and the Brain–Heart Connection in Alzheimer Disease

    Article • Microorganisms, March 2020, MDPI AG

    Professor George Perry

  91. Polyphenols in Alzheimer’s Disease and in the Gut–Brain Axis

    Article • Microorganisms, January 2020, MDPI AG

    Professor George Perry

  92. Hippocampal Unicellular Recordings and Hippocampal-dependent Innate Behaviors in an Adolescent Mouse Model of Alzheimer’s disease

    Article • BIO-PROTOCOL, January 2020, Bio-Protocol, LLC

    Professor George Perry

  93. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, January 2020, Elsevier

    Professor George Perry

  94. Dementia Pugilistica Revisited

    Article • January 2020, IOS Press

    Professor George Perry

  95. Neuropathology in Consecutive Forensic Consultation Cases with a History of Remote Traumatic Brain Injury

    Article • January 2020, IOS Press

    Professor George Perry

  96. No Evidence of Chronic Traumatic Encephalopathy Pathology or Increased Neurodegenerative Proteinopathy in Former Military Service Members

    Article • January 2020, IOS Press

    Professor George Perry

  97. Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges

    Article • January 2020, IOS Press

    Professor George Perry

  98. The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features

    Article • January 2020, IOS Press

    Professor George Perry

  99. Neuropathology in Consecutive Forensic Consultation Cases with a History of Remote Traumatic Brain Injury

    Article • Journal of Alzheimer’s Disease, November 2019, IOS Press

    Professor George Perry

  100. Biomarker-guided clustering of Alzheimer's disease clinical syndromes

    Article • Neurobiology of Aging, November 2019, Elsevier

    Professor George Perry

  101. Current research in biotechnology: Exploring the biotech forefront

    Article • Current Research in Biotechnology, November 2019, Elsevier

    Professor George Perry, Professor Francisco Antonio Macias

  102. Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma

    Article • Brain, October 2019, Oxford University Press (OUP)

    Professor George Perry

  103. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration

    Article • Molecular and Cellular Neuroscience, October 2019, Elsevier

    Professor George Perry

  104. Gait Disorders in Alzheimer’s Disease and Other Dementias: There is Something in the Way You Walk

    Article • Journal of Alzheimer’s Disease, September 2019, IOS Press

    Professor George Perry

  105. Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological Study

    Article • Journal of Alzheimer’s Disease, September 2019, IOS Press

    Dr. Benjamín Floran, José Luna, Professor George Perry

  106. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, August 2019, Elsevier

    Professor Paula I. Moreira, Professor George Perry

  107. Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, August 2019, Elsevier

    Professor George Perry

  108. Differences in structure and function between human and murine tau

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, August 2019, Elsevier

    Professor George Perry

  109. Neuropsychiatric Disturbances and Diabetes Mellitus: The Role of Oxidative Stress

    Article • Oxidative Medicine and Cellular Longevity, July 2019, Hindawi Publishing Corporation

    Professor George Perry, Maria Luca

  110. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders

    Article • Neurotherapeutics, July 2019, Springer Science + Business Media

    Professor George Perry

  111. The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation

    Article • Laboratory Investigation, July 2019, Elsevier

    Professor George Perry

  112. Editorial: Oxidative Stress Revisited—Major Role in Vascular Diseases

    Article • Frontiers in Physiology, June 2019, Frontiers

    Professor George Perry

  113. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice

    Article • Journal of Alzheimer’s Disease, June 2019, IOS Press

    Professor George Perry

  114. Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective

    Article • Journal of Alzheimer’s Disease, June 2019, IOS Press

    Professor George Perry

  115. MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents

    Article • Seminars in Cancer Biology, June 2019, Elsevier

    Professor George Perry

  116. Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease

    Article • Alzheimer s & Dementia, May 2019, Wiley

    Professor George Perry

  117. Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease

    Article • Alzheimer s & Dementia, May 2019, Wiley

    Professor George Perry

  118. Rapid method towards proteomic analysis of dried blood spots by MALDI mass spectrometry

    Article • Clinical Mass Spectrometry, April 2019, Elsevier

    Professor George Perry

  119. Single-channel permeability and glycerol affinity of human aquaglyceroporin AQP3

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, April 2019, Elsevier

    Professor George Perry

  120. Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology

    Article • Frontiers in Pharmacology, March 2019, Frontiers

    Professor George Perry

  121. The Transformative Possibilities of the Microbiota and Mycobiota for Health, Disease, Aging, and Technological Innovation.

    Article • Biomedicines, March 2019, MDPI AG

    Professor George Perry

  122. The Alzheimer Precision Medicine Initiative

    Article • Journal of Alzheimer’s Disease, March 2019, IOS Press

    Professor George Perry

  123. The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research

    Article • Ethnicity & Disease, February 2019, Ethnicity and Disease Inc

    Professor George Perry

  124. No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study

    Article • Journal of Alzheimer’s Disease, February 2019, IOS Press

    Professor George Perry

  125. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases

    Article • Neurology, February 2019, Wolters Kluwer Health

    Professor George Perry

  126. Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study

    Article • Alzheimer s Research & Therapy, January 2019, Springer Science + Business Media

    Professor George Perry

  127. The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease

    Article • Brain Pathology, January 2019, Wiley

    Professor George Perry

  128. Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges

    Article • Journal of Alzheimer’s Disease, January 2019, IOS Press

    Professor George Perry

  129. COMMENTARY: DEVELOPMENT OF THE BLOOD-BASED ALZHEIMER’S DISEASE LIQUID BIOPSY

    Article • The Journal of Prevention of Alzheimer s Disease, January 2019, SERDI

    Professor George Perry

  130. Preface

    Article • Mini-Reviews in Medicinal Chemistry, December 2018, Bentham Science Publishers

    Professor George Perry

  131. Vascular Oxidative Stress: Impact and Therapeutic Approaches

    Article • Frontiers in Physiology, December 2018, Frontiers

    Professor George Perry

  132. Preface

    Article • Letters in Drug Design & Discovery, November 2018, Bentham Science Publishers

    Professor George Perry

  133. An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson’s Disease1

    Article • Journal of Alzheimer’s Disease, October 2018, IOS Press

    Professor George Perry

  134. Genetic Risk of Alzheimer’s Disease: Three Wishes Now That the Genie is Out of the Bottle

    Article • Journal of Alzheimer’s Disease, October 2018, IOS Press

    Professor George Perry

  135. From Oxidative Stress to Ageing via Lifestyle, Nutraceuticals, Polypharmacy, and Neuropsychological Factors

    Article • Oxidative Medicine and Cellular Longevity, September 2018, Hindawi Publishing Corporation

    Dr ilaria peluso, Prof. MA Kamal, Professor George Perry

  136. Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles

    Article • Cell Metabolism, September 2018, Elsevier

    Professor George Perry

  137. Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors

    Article • Frontiers in Neurology, August 2018, Frontiers

    Professor George Perry

  138. Association of cerebrospinal fluid α‐synuclein with total and phospho‐tau 181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers

    Article • Alzheimer s & Dementia, July 2018, Wiley

    Professor George Perry

  139. Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints

    Article • Alzheimer s & Dementia, July 2018, Wiley

    Professor George Perry

  140. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology

    Article • Journal of Alzheimer’s Disease, June 2018, IOS Press

    Professor George Perry

  141. Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade

    Article • Journal of Alzheimer’s Disease, June 2018, IOS Press

    Daniela Puzzo, Professor George Perry

  142. Preface

    Article • Journal of Alzheimer’s Disease, June 2018, IOS Press

    Professor George Perry, Professor Paula I. Moreira

  143. Gibbs Free-Energy Gradient along the Path of Glucose Transport through Human Glucose Transporter 3

    Article • ACS Chemical Neuroscience, June 2018, American Chemical Society (ACS)

    Professor George Perry

  144. Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model

    Article • Journal of Biological Chemistry, June 2018, Elsevier

    Professor George Perry

  145. Drug-Abuse Nanotechnology: Opportunities and Challenges

    Article • ACS Chemical Neuroscience, May 2018, American Chemical Society (ACS)

    Professor George Perry

  146. Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data

    Article • Journal of Alzheimer’s Disease, May 2018, IOS Press

    Professor George Perry

  147. Pathomechanisms of TDP-43 in neurodegeneration

    Article • Journal of Neurochemistry, May 2018, Wiley

    Professor George Perry

  148. Correction to: Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders

    Article • Molecular Neurobiology, April 2018, Springer Science + Business Media

    Professor George Perry

  149. Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, April 2018, IOS Press

    Professor George Perry

  150. Precision pharmacology for Alzheimer’s disease

    Article • Pharmacological Research, April 2018, Elsevier

    Professor George Perry

  151. Expression of growth hormone gene in the baboon eye

    Article • Experimental Eye Research, April 2018, Elsevier

    Professor George Perry

  152. Towards an Integrative Understanding of tRNA Aminoacylation–Diet–Host–Gut Microbiome Interactions in Neurodegeneration

    Article • Nutrients, March 2018, MDPI AG

    Professor George Perry

  153. Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders

    Article • Molecular Neurobiology, March 2018, Springer Science + Business Media

    Professor George Perry

  154. Birth of JAD: 20 Years Later

    Article • Journal of Alzheimer’s Disease, March 2018, IOS Press

    Professor George Perry

  155. Anthocyanins and its biological & therapeutic characters

    Article • Current Pharmaceutical Design, February 2018, Bentham Science Publishers

    Gjumrakch Aliev, Professor George Perry, Dr Luciana Scotti, Professor Da Yong Lu, Prof. MA Kamal, Pallaval Veerabramhachari, Marcus Tullius Scotti

  156. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology

    Article • Journal of Alzheimer’s Disease, February 2018, IOS Press

    Professor George Perry, Professor Marcela Reale

  157. Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex

    Article • Molecular Neurodegeneration, February 2018, Springer Science + Business Media

    Professor George Perry

  158. Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta-analysis in human pathological specimens

    Article • Free Radical Biology and Medicine, February 2018, Elsevier

    Professor George Perry

  159. Iron·ic facts about dementia

    Article • Journal of Neurology Neurosurgery & Psychiatry, January 2018, BMJ

    Professor George Perry

  160. Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer’s Diseased Brains by MALDI-TOF MS with MS/MS

    Article • ACS Chemical Neuroscience, January 2018, American Chemical Society (ACS)

    Professor George Perry

  161. Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers

    Article • Current Alzheimer Research, January 2018, Bentham Science Publishers

    Professor George Perry

  162. Preface

    Article • Letters in Drug Design & Discovery, January 2018, Bentham Science Publishers

    Professor George Perry

  163. Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects

    Article • Nanoscale, January 2018, Royal Society of Chemistry

    Professor George Perry

  164. Foreword

    Article • January 2018, Elsevier

    Professor George Perry

  165. Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and α-synuclein toward in vivo analysis

    Article • Journal of Mass Spectrometry, December 2017, Wiley

    Professor George Perry

  166. Thermodynamics of Amyloid-β Fibril Elongation: Atomistic Details of the Transition State

    Article • ACS Chemical Neuroscience, December 2017, American Chemical Society (ACS)

    Professor George Perry

  167. Preface

    Article • Mini-Reviews in Medicinal Chemistry, December 2017, Bentham Science Publishers

    Professor George Perry

  168. Affinity and path of binding xylopyranose unto E. coli xylose permease

    Article • Biochemical and Biophysical Research Communications, December 2017, Elsevier

    Professor George Perry

  169. The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features

    Article • Journal of Alzheimer’s Disease, November 2017, IOS Press

    Professor George Perry

  170. Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer’s Disease

    Article • The Open Neurology Journal, November 2017, Bentham Science Publishers

    Professor George Perry

  171. Dementia Pugilistica Revisited

    Article • Journal of Alzheimer’s Disease, November 2017, IOS Press

    Professor George Perry

  172. Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study

    Article • Alzheimer s & Dementia, October 2017, Wiley

    Dr Davide Vito Moretti, Professor George Perry, Dr. LuAnn Nowak Etcher

  173. Advances in Alzheimer’s Diagnosis and Therapy: The Implications of Nanotechnology

    Article • Trends in Biotechnology, October 2017, Elsevier

    Professor George Perry

  174. Asking the Right Questions

    Article • Negotiation Journal, October 2017, The MIT Press

    Professor George Perry

  175. BARHL1 Is Downregulated in Alzheimer’s Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways

    Article • Genes, September 2017, MDPI AG

    Professor George Perry, Dr Vasco Azevedo

  176. Molecular Pathways in Normal Aging and Neurodegeneration: Mechanisms and Therapeutics

    Article • Journal of Alzheimer’s Disease, September 2017, IOS Press

    Professor George Perry

  177. Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders

    Article • Biochemical Society Transactions, August 2017, Portland Press Ltd.

    Professor George Perry

  178. Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model

    Article • Human Molecular Genetics, July 2017, Oxford University Press (OUP)

    Professor George Perry

  179. TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, June 2017, IOS Press

    Professor George Perry

  180. Meet Our Editor

    Article • Current Clinical Pharmacology, June 2017, Bentham Science Publishers

    Professor George Perry

  181. The Vascular Impairment of Cognition Classification Consensus Study

    Article • Alzheimer s & Dementia, June 2017, Elsevier

    Professor George Perry, Dr Davide Vito Moretti, Dr. LuAnn Nowak Etcher

  182. Elongation affinity, activation barrier, and stability of Aβ42 oligomers/fibrils in physiological saline

    Article • Biochemical and Biophysical Research Communications, May 2017, Elsevier

    Professor George Perry

  183. Nutritional supplements and dementia

    Article • Clinical Nutrition, April 2017, Elsevier

    Professor George Perry

  184. Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer’s Disease

    Article • ACS Chemical Neuroscience, February 2017, American Chemical Society (ACS)

    Professor George Perry, Ricardo Lleonart

  185. Meet Our Editor

    Article • Letters in Drug Design & Discovery, January 2017, Bentham Science Publishers

    Professor George Perry

  186. Meet Our Co-Editor

    Article • Mini-Reviews in Medicinal Chemistry, January 2017, Bentham Science Publishers

    Professor George Perry

  187. Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer’s disease

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2017, Taylor & Francis

    Professor George Perry, Dr Carlos Areche, Alberto Cornejo, julio caballero

  188. Metals and Mitochondria in Neurodegeneration

    Article • January 2017, Elsevier

    Professor George Perry

  189. Brain Composition: Age-Related Changes ☆

    Article • January 2017, Elsevier

    Professor George Perry

  190. Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer’s Disease

    Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

    Professor George Perry

  191. Tau Proteins

    Article • January 2017, Elsevier

    Professor George Perry

  192. Microbes and Alzheimer's Disease

    Article • January 2017, IOS Press

    Professor George Perry

  193. Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease

    Article • Current Alzheimer Research, November 2016, Bentham Science Publishers

    Professor George Perry

  194. Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology

    Article • Journal of Alzheimer’s Disease, November 2016, IOS Press

    Frederick P Bellinger, Professor George Perry, Professor Paula I. Moreira

  195. Functional and Genomic Features of Human Genes Mutated in Neuropsychiatric Disorders

    Article • The Open Neurology Journal, November 2016, Bentham Science Publishers

    Professor Diego A Forero, Professor George Perry

  196. Modulation of Parkinson’s Disease Associated Protein Rescues Alzheimer’s Disease Degeneration

    Article • Journal of Alzheimer’s Disease, November 2016, IOS Press

    Professor George Perry

  197. Meet Our Associate Editor

    Article • Current Alzheimer Research, November 2016, Bentham Science Publishers

    Professor George Perry

  198. The Role of the Iron Stain in Assessing Intracranial Hemorrhage

    Article • The Open Neurology Journal, October 2016, Bentham Science Publishers

    Professor George Perry

  199. Promise from the Sea

    Article • Marine Drugs, October 2016, MDPI AG

    Professor George Perry

  200. Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, October 2016, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  201. Molecular Mapping Alzheimer's Disease: MALDI Imaging of Formalin-fixed, Paraffin-embedded Human Hippocampal Tissue

    Article • The Open Neurology Journal, September 2016, Bentham Science Publishers

    Professor George Perry

  202. Oxidative Stress Induces Senescence in Cultured RPE Cells

    Article • The Open Neurology Journal, August 2016, Bentham Science Publishers

    Professor George Perry

  203. Meet Our Editorial Board Member:

    Article • Current Aging Science, July 2016, Bentham Science Publishers

    Professor George Perry

  204. Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein

    Article • Aging Cell, July 2016, Wiley

    Professor George Perry

  205. Nucleic acid oxidative damage in Alzheimer's disease—explained by the hepcidin-ferroportin neuronal iron overload hypothesis?

    Article • Journal of Trace Elements in Medicine and Biology, June 2016, Elsevier

    Professor George Perry

  206. Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities

    Article • Oncotarget, May 2016, Impact Journals, LLC

    Professor George Perry

  207. High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer’s disease

    Article • Scientific Reports, April 2016, Nature

    Professor George Perry

  208. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse

    Article • Journal of Alzheimer’s Disease, April 2016, IOS Press

    Dr. Juan Pedro Luna-Arias, Professor George Perry, José Luna, Dr. Benjamín Floran, Juan Pedro Luna-Arias

  209. Meta-analysis of Telomere Length in Alzheimer’s Disease

    Article • The Journals of Gerontology Series A, April 2016, Oxford University Press (OUP)

    Professor Diego A Forero, Professor George Perry

  210. Microbes and Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, April 2016, IOS Press

    Professor George Perry, Professor Douglas B Kell, Dr Christopher Carter, Ruth Itzhaki

  211. Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer's disease

    Article • Environmental Research, April 2016, Elsevier

    Professor George Perry

  212. Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer’s Brains

    Article • ACS Chemical Neuroscience, March 2016, American Chemical Society (ACS)

    Professor George Perry

  213. Telomere length in Parkinson's disease: A meta-analysis

    Article • Experimental Gerontology, March 2016, Elsevier

    Professor Diego A Forero, Professor George Perry

  214. Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease

    Article • Scientific Reports, February 2016, Nature

    Professor George Perry

  215. 1,3-propanediol binds deep inside the channel to inhibit water permeation through aquaporins

    Article • Protein Science, January 2016, Wiley

    Professor George Perry

  216. Current needs for human and medical genomics research infrastructure in low and middle income countries: Table 1

    Article • Journal of Medical Genetics, January 2016, BMJ

    Professor Diego A Forero, Professor George Perry, Professor Wei Wang

  217. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Article • Autophagy, January 2016, Taylor & Francis

    Professor CIRO ISIDORO, Dr Akira Matsuura, Prof Hirokazu Arimoto, Professor Marc Diederich, Maria Vaccaro, Professor Abdel Halim Harrath, Professor Hyun Kyu Song, Dr Takeshi Noda, Dr Regina Menezes, Dr Janos KristonVizi, Cristina Muñoz-Pinedo, Professor Nektarios Tavernarakis, Juan Segura-Aguilar, Professor Marc Lecuit, Leonardo Travassos, Prof Robert Bryson-Richardson, Isabelle Dugail, PD Dipl.-Ing. Dr. techn. Werner J Kovacs, Dr Luca Galluzzi, Dr Reinhard Dechant, Dr. Sandra Moreno, Maurizio Molinari, Dr Vasilis J Promponas, Professor Günther Weindl, Dr Marc Etienne Poirot, Professor Paula I. Moreira, Maria João Sousa, Dr Janna Morrison, Professor Mark Cragg, Executive Director, The Hormel Institute Robert Clarke, Dr Eleonora García Véscovi, Paula Ludovico, Professor Jean-François Beaulieu, Shile Huang, Professor George Perry, Professor Godefridus J Peters, Shuo-Chien Ling, Professor Jiwu Wei, Deepak Shukla, Dave Bridges

  218. Overview of Alzheimer’s Disease and Some Therapeutic Approaches Targeting Aβby Using Several Synthetic and Herbal Compounds

    Article • Oxidative Medicine and Cellular Longevity, January 2016, Hindawi Publishing Corporation

    Professor George Perry

  219. Editor Note on Mass Spectra for Revealing Disease - Associated Pathways

    Article • Mass Spectrometry & Purification Techniques, January 2016, OMICS Publishing Group

    Professor George Perry

  220. Management of Neuro Degenerative Diseases of Elderly Adults

    Article • Journal of Alzheimer’s Disease & Parkinsonism, January 2016, OMICS Publishing Group

    Professor George Perry

  221. Insights into the structural patterns of the antileishmanial activity of bi- and tricyclic N-heterocycles

    Article • Organic & Biomolecular Chemistry, January 2016, Royal Society of Chemistry

    Professor George Perry, Ricardo Lleonart

  222. Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria

    Article • January 2016, Elsevier

    Professor Paula I. Moreira, Professor George Perry

  223. Oxidative Stress and Alzheimer’s Disease

    Article • January 2016, Springer Science + Business Media

    Professor George Perry

  224. PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease

    Article • Human Molecular Genetics, December 2015, Oxford University Press (OUP)

    Professor George Perry

  225. Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer’s disease

    Article • Molecular Psychiatry, December 2015, Nature

    Professor George Perry

  226. Recent Advances in Medicinal Chemistry

    Article • December 2015, Bentham Science Publishers

    Professor George Perry

  227. Alterations of the X Chromosome in Lymphocytes of Alzheimer’s Disease Patients

    Article • Current Alzheimer Research, November 2015, Bentham Science Publishers

    Professor George Perry

  228. A Cultivated Form of a Red Seaweed (Chondrus crispus), Suppresses β-Amyloid-Induced Paralysis in Caenorhabditis elegans

    Article • Marine Drugs, October 2015, MDPI AG

    Professor George Perry

  229. Redox Status and Neuro Inflammation Indexes in Cerebellum and Motor Cortex of Wistar Rats Supplemented with Natural Sources of Omega-3 Fatty Acids and Astaxanthin: Fish Oil, Krill Oil, and Algal Biomass

    Article • Marine Drugs, September 2015, MDPI AG

    Professor George Perry

  230. Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point

    Article • Immunity, September 2015, Elsevier

    Professor George Perry

  231. Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis

    Article • Translational Neurodegeneration, July 2015, Springer Science + Business Media

    Professor George Perry

  232. Meet Our Editorial Board Member:

    Article • Current Vascular Pharmacology, July 2015, Bentham Science Publishers

    Professor George Perry

  233. Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer d...

    Article • Environmental Research, July 2015, Elsevier

    Professor George Perry

  234. Oxidative damage is correlated with mitochondrial autophagy

    Article • Alzheimer s & Dementia, July 2015, Elsevier

    Professor George Perry

  235. Chlamydia pneumoniae promotes dysfunction of pancreatic beta cells

    Article • Cellular Immunology, June 2015, Elsevier

    Professor George Perry

  236. Chronic Effects of Mild Neurotrauma

    Article • Journal of Neuropathology & Experimental Neurology, June 2015, Oxford University Press (OUP)

    Professor George Perry

  237. Miro1 deficiency in amyotrophic lateral sclerosis

    Article • Frontiers in Aging Neuroscience, May 2015, Frontiers

    Professor George Perry

  238. Meet Our Editorial Board Member:

    Article • Mini-Reviews in Medicinal Chemistry, May 2015, Bentham Science Publishers

    Professor George Perry

  239. Posttranslational modifications of α-tubulin in alzheimer disease

    Article • Translational Neurodegeneration, May 2015, Springer Science + Business Media

    Professor George Perry

  240. From Neurodegeneration to Brain Health: An Integrated Approach

    Article • Journal of Alzheimer’s Disease, May 2015, IOS Press

    Professor George Perry

  241. Curcumin/Melatonin Hybrid 5-(4-Hydroxy-phenyl)-3-oxo-pentanoic Acid [2-(5-Methoxy-1H-indol-3-yl)-ethyl]-amide Ameliorates AD-Like Pathology in the APP/PS1 Mouse Model

    Article • ACS Chemical Neuroscience, May 2015, American Chemical Society (ACS)

    Professor George Perry

  242. Alternative neural circuitry that might be impaired in the development of Alzheimer disease

    Article • Frontiers in Neuroscience, April 2015, Frontiers

    Professor George Perry

  243. Raúl Mena: 1953–2014

    Article • Journal of Alzheimer’s Disease, March 2015, IOS Press

    Professor George Perry

  244. Meet the Editorial Board

    Article • Current Protein and Peptide Science, March 2015, Bentham Science Publishers

    Professor George Perry

  245. Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau

    Article • The Open Neurology Journal, February 2015, Bentham Science Publishers

    Professor George Perry

  246. Overview

    Article • Mini-Reviews in Medicinal Chemistry, February 2015, Bentham Science Publishers

    Professor George Perry, Atta ur Rahman

  247. Two Hundred Treasured Issues!

    Article • Journal of Alzheimer’s Disease, February 2015, IOS Press

    Professor George Perry

  248. Neuropathology and Ophthalmic Pathology

    Article • Laboratory Investigation, February 2015, Elsevier

    Professor George Perry

  249. Cerebrovascular and mitochondrial abnormalities in Alzheimer’s disease: a brief overview

    Article • Journal of Neural Transmission, January 2015, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  250. A Clinical Study of Lupron Depot in the Treatment of Women with Alzheimer's Disease: Preservation of Cognitive Function in Patients Taking an Acetylcholinesterase Inhibitor and Treated with High Dose Lupron Over 48 Weeks

    Article • Journal of Alzheimer’s Disease, January 2015, IOS Press

    Professor George Perry

  251. Cellular Pathology of Alzheimer Disease

    Article • Cell & Developmental Biology, January 2015, OMICS Publishing Group

    Professor George Perry

  252. Editor Note

    Article • Biological Systems Open Access, January 2015, OMICS Publishing Group

    Professor George Perry

  253. Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET

    Article • International Journal of Knowledge Discovery in Bioinformatics, January 2015, IGI Global

    Professor George Perry

  254. Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau

    Article • The Open Neurology Journal, December 2014, Bentham Science Publishers

    Professor George Perry

  255. Global warming and neurodegenerative disorders: speculations on their linkage

    Article • Bioimpacts, November 2014, International Society for Phytocosmetic Scicences

    Professor George Perry

  256. Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease

    Article • Current Alzheimer Research, November 2014, Bentham Science Publishers

    Professor George Perry

  257. Precision medicine using individualized biosimulations of drug dosing: Alzheimer's disease

    Article • October 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Professor George Perry

  258. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, August 2014, Elsevier

    Professor George Perry

  259. Recent Advances in Medicinal Chemistry

    Article • July 2014, Bentham Science Publishers

    Professor George Perry, Atta ur Rahman

  260. Preface

    Article • July 2014, Bentham Science Publishers

    Professor George Perry

  261. Parallels Between Major Depressive Disorder and Alzheimer’s Disease: Role of Oxidative Stress and Genetic Vulnerability

    Article • Cellular and Molecular Neurobiology, June 2014, Springer Science + Business Media

    Professor George Perry

  262. Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group

    Article • Movement Disorders, April 2014, Wiley

    Professor George Perry

  263. Accumulation of Intraneuronal Amyloid-β is Common in Normal Brain

    Article • Current Alzheimer Research, April 2014, Bentham Science Publishers

    Professor George Perry, Sergio Ferreira

  264. The complexities of the pathology–pathogenesis relationship in Alzheimer disease

    Article • Biochemical Pharmacology, April 2014, Elsevier

    Professor George Perry

  265. Plaques and tangles: Birthmarks of the aging soul

    Article • Biochemical Pharmacology, April 2014, Elsevier

    Professor George Perry

  266. Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass

    Article • Neuroscience Bulletin, April 2014, Springer Science + Business Media

    Professor George Perry

  267. Low Plasma Leptin in Cognitively Impaired ADNI Subjects: Gender Differences and Diagnostic and Therapeutic Potential

    Article • Current Alzheimer Research, March 2014, Bentham Science Publishers

    Professor George Perry, Dr David W Fardo

  268. Ethics Review as a Catalyst for Progress

    Article • Journal of Alzheimer’s Disease, March 2014, IOS Press

    Professor George Perry

  269. A New Outlook for Alzheimer’s Disease

    Article • Atlas Journal of Medical and Biological Sciences, February 2014, Atlas Publishing, LP

    Professor George Perry

  270. Phosphorylation of tau protein at sites Ser396-404is one of the earliest events in Alzheimer's disease and Down syndrome

    Article • Neuropathology and Applied Neurobiology, January 2014, Wiley

    Professor George Perry

  271. Methemoglobinemia—A biomarker and a link to ferric iron accumulation in Alzheimer’s disease

    Article • Advances in Bioscience and Biotechnology, January 2014, Scientific Research Publishing, Inc,

    Professor George Perry

  272. Looking at Alzheimer‘s disease from a different angle

    Article • Future Neurology, January 2014, Future Medicine

    Professor George Perry

  273. Apolipoprotein E4 Prevents Growth of Malaria at the Intraerythrocyte Stage: Implications For Diff erences in Racial Susceptibility to Alzheimer’s Disease

    Article • Journal of Health Care for the Poor and Underserved, January 2014, Project Muse

    Professor George Perry

  274. Neuropsychiatric genetics in developing countries: Current challenges

    Article • World Journal of Psychiatry, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor George Perry

  275. Differential Network Analyses of Alzheimer’s Disease Identify Early Events in Alzheimer’s Disease Pathology

    Article • International Journal of Alzheimer s Disease, January 2014, Hindawi Publishing Corporation

    Professor George Perry

  276. Preface

    Article • January 2014, Elsevier

    Professor George Perry

  277. Pathogenesis of Alzheimer’s Disease

    Article • January 2014, Springer Science + Business Media

    Professor George Perry

  278. Recent Advances in Medicinal Chemistry

    Article • January 2014, Elsevier

    Professor George Perry

  279. Neuropathology of Alzheimer's Disease

    Article • January 2014, Elsevier

    Professor George Perry

  280. Proteolytic Cleavage of Polymeric Tau Protein by Caspase-3: Implications for Alzheimer Disease

    Article • Journal of Neuropathology & Experimental Neurology, December 2013, Oxford University Press (OUP)

    Professor George Perry

  281. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases

    Article • Translational Psychiatry, December 2013, Springer Science + Business Media

    Professor George Perry

  282. A Low-Molecular-Weight Ferroxidase Is Increased in the CSF of sCJD Cases: CSF Ferroxidase and Transferrin as Diagnostic Biomarkers for sCJD

    Article • Antioxidants & Redox Signaling, November 2013, Mary Ann Liebert Inc

    Professor George Perry, Dr. Justin Greenlee

  283. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis

    Article • Neurobiology of Disease, November 2013, Elsevier

    Professor George Perry

  284. Faculty of 1000 evaluation for Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.

    Article • October 2013, Faculty of 1000, Ltd.

    Professor George Perry

  285. Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain

    Article • Journal of Neuroinflammation, October 2013, Springer Science + Business Media

    Professor George Perry

  286. Tryptamine Induces Axonopathy and Mitochondriopathy Mimicking Neurodegenerative Diseases via Tryptophanyl-tRNA Deficiency

    Article • Current Alzheimer Research, October 2013, Bentham Science Publishers

    Professor George Perry

  287. Is exercise-in-a-bottle likely to proffer new insights into Alzheimer's disease?

    Article • Journal of Neurochemistry, September 2013, Wiley

    Professor George Perry, Professor Paula I. Moreira

  288. Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance

    Article • Journal of Neurochemistry, August 2013, Wiley

    Professor George Perry

  289. Larry Sparks: Innovator and Iconoclast

    Article • Journal of Alzheimer’s Disease, August 2013, IOS Press

    Professor George Perry

  290. Modification of Amyloid-β1-42 Fibril Structure by Methionine-35 Oxidation

    Article • Journal of Alzheimer’s Disease, August 2013, IOS Press

    Professor George Perry

  291. Amyloid β peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system

    Article • Neurobiology of Aging, August 2013, Elsevier

    Professor George Perry

  292. Presenilin mutations impair mitochondrial dynamics in neurons

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Professor George Perry

  293. Neuronal leptin resistance in Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Professor George Perry

  294. Methemoglobin catabolism and Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Professor George Perry

  295. Flux and metabolite pathway mapping in the aging and Alzheimer's disease hippocampus

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Professor George Perry

  296. Mitochondrial DNA Oxidative Damage and Repair in Aging and Alzheimer's Disease

    Article • Antioxidants & Redox Signaling, June 2013, Mary Ann Liebert Inc

    Professor George Perry, Professor Paula I. Moreira

  297. Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links

    Article • Free Radical Research, May 2013, Taylor & Francis

    Professor George Perry, Professor Paula I. Moreira

  298. Are Alzheimer's Disease and Aging Evolutionary?

    Article • Journal of Alzheimer’s Disease, May 2013, IOS Press

    Professor George Perry

  299. Mitochondrial Abnormalities in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease

    Article • Current Alzheimer Research, April 2013, Bentham Science Publishers

    Professor Paula I. Moreira, Professor George Perry

  300. The Structures of the E22Δ Mutant-Type Amyloid-β Alloforms and the Impact of E22Δ Mutation on the Structures of the Wild-Type Amyloid-β Alloforms

    Article • ACS Chemical Neuroscience, February 2013, American Chemical Society (ACS)

    Professor George Perry, Orkid Coskuner, Orkid Coskuner-Weber

  301. Tackling the Elusive Challenges Relevant to Conquering the 100-Plus Year Old Problem of Alzheimer’s Disease

    Article • Current Alzheimer Research, January 2013, Bentham Science Publishers

    Professor George Perry

  302. Tackling the Elusive Challenges Relevant to Conquering the 100-Plus Year Old Problem of Alzheimer's Disease

    Article • Current Alzheimer Research, January 2013, Bentham Science Publishers

    Professor George Perry

  303. Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer’s Disease

    Article • Oxidative Medicine and Cellular Longevity, January 2013, Hindawi Publishing Corporation

    Professor George Perry, Professor Paula I. Moreira

  304. Nutrients and Food Constituents in Cognitive Decline and Neurodegenerative Disease

    Article • January 2013, Elsevier

    Professor George Perry

  305. Foreword (The Largest Unmet Market: Chronic Diseases of Aging)

    Article • Mini-Reviews in Medicinal Chemistry, January 2013, Bentham Science Publishers

    Professor George Perry

  306. DNA Damage in Alzheimer Disease Lymphocytes and Its Relation to Premature Centromere Division

    Article • Neurodegenerative Diseases, January 2013, Karger Publishers

    Professor George Perry

  307. Deconstructing Mitochondrial Dysfunction in Alzheimer Disease

    Article • Oxidative Medicine and Cellular Longevity, January 2013, Hindawi Publishing Corporation

    Professor George Perry

  308. Cloning’s Promise

    Article • Cloning & Transgenesis, January 2013, OMICS Publishing Group

    Professor George Perry

  309. Oxidative Stress and Alzheimer’s Disease

    Article • January 2013, Springer Science + Business Media

    Professor George Perry

  310. Abnormal Mitochondrial Dynamics in the Pathogenesis of Alzheimer's Disease

    Article • January 2013, IOS Press

    Professor George Perry

  311. Preface

    Article • January 2013, IOS Press

    Professor George Perry

  312. Abnormal Mitochondrial Dynamics in the Pathogenesis of Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, December 2012, IOS Press

    Professor George Perry

  313. Alzheimer's Disease: Advances for a New Century

    Article • Journal of Alzheimer’s Disease, December 2012, IOS Press

    Professor George Perry

  314. Imaging the Onset and Progression of Alzheimer's Disease: Implications for Prevention Trials

    Article • Journal of Alzheimer’s Disease, December 2012, IOS Press

    Professor George Perry

  315. Inge Grundke-Iqbal: A Legacy of Tau in the Etiology of Alzheimer Disease (1937–2012)

    Article • Journal of Alzheimer’s Disease, December 2012, IOS Press

    Professor George Perry

  316. Foreword [The Largest Unmet Market: Chronic Diseases of Aging]

    Article • Mini-Reviews in Medicinal Chemistry, December 2012, Bentham Science Publishers

    Professor George Perry

  317. Foreword [The Largest Unmet Market: Chronic Diseases of Aging]

    Article • Mini-Reviews in Medicinal Chemistry, December 2012, Bentham Science Publishers

    Professor George Perry

  318. Isotyping the Human TOMM40 Variable-Length Polymorphism by Gene Amplification and Restriction Digest

    Article • Current Alzheimer Research, November 2012, Bentham Science Publishers

    Professor George Perry

  319. The impairment of insulin signaling in Alzheimer's disease

    Article • IUBMB Life, November 2012, Wiley

    Professor George Perry, Professor Paula I. Moreira

  320. Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress

    Article • Archives of Medical Research, November 2012, Elsevier

    Professor George Perry

  321. Editorial - Chronic or Late Lyme Neuroborreliosis: Present and Future

    Article • The Open Neurology Journal, October 2012, Bentham Science Publishers

    Professor George Perry, Judith Miklossy

  322. Editorial [Special Issue in Honor of the 70th Birthday of Dr. Atta-ur-Rahman, FRS]

    Article • Mini-Reviews in Medicinal Chemistry, September 2012, Bentham Science Publishers

    Professor George Perry

  323. Mark Smith: Pioneer of Alzheimer Disease Research

    Article • Neurotoxicity Research, July 2012, Springer Science + Business Media

    Professor George Perry

  324. β-Amyloid 1-42 induces physiological transcriptional regulation of BACE1

    Article • Journal of Neurochemistry, July 2012, Wiley

    Professor George Perry

  325. Reanimating basal forebrain cholinergic neurons in electrophysiology biosimulations using COPASI software

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Professor George Perry

  326. LRRK2 Directly Interacts with DLP1 to Regulate Mitochondrial Dynamics and Function

    Article • Microscopy and Microanalysis, July 2012, Oxford University Press (OUP)

    Professor George Perry

  327. Journal of Huntington's Disease – The Family Gets Bigger

    Article • Journal of Alzheimer’s Disease, June 2012, IOS Press

    Professor George Perry

  328. R-_-Lipoic Acid as a Potent Agent of Mitochondrial Protectionin Alzheimer’s Disease

    Article • June 2012, Taylor & Francis

    Professor George Perry

  329. Structures and free energy landscapes of aqueous zinc(II)-bound amyloid-β(1–40) and zinc(II)-bound amyloid-β(1–42) with dynamics

    Article • JBIC Journal of Biological Inorganic Chemistry, June 2012, Springer Science + Business Media

    Professor George Perry, Orkid Coskuner, Orkid Coskuner-Weber

  330. Oxidative Damage to RNA in Aging and Neurodegenerative Disorders

    Article • Neurotoxicity Research, June 2012, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  331. Molecular neuropathogenesis of Alzheimer’s disease: an interaction model stressing the central role of oxidative stress

    Article • Future Neurology, May 2012, Future Medicine

    Professor George Perry

  332. Iron chelation and nanoparticle target delivery in the development of new multifunctional disease-modifying drugs for Alzheimer’s disease

    Article • Therapeutic Delivery, May 2012, Future Science

    Professor George Perry

  333. Nanoparticle Delivery of Transition-Metal Chelators to the Brain: Oxidative Stress will Never See it Coming!

    Article • CNS & Neurological Disorders - Drug Targets, April 2012, Bentham Science Publishers

    Professor George Perry

  334. Guidelines for the use and interpretation of assays for monitoring autophagy

    Article • Autophagy, April 2012, Taylor & Francis

    Dave Bridges, Professor CIRO ISIDORO, Professor George Perry, Dr Takeshi Noda, Professor Nektarios Tavernarakis, Matthias Gaestel, Dr Francesca Demarchi, Maria Vaccaro, Juan Segura-Aguilar, Leonardo Travassos, Manoj B Menon, Isabelle Dugail, Dr Legembre Patrick, Dr Marc Etienne Poirot, Professor Paula I. Moreira, Executive Director, The Hormel Institute Robert Clarke, Professor Godefridus J Peters, Professor Brigitte Galliot, Professor Luca Scorrano

  335. Therapeutic Opportunities in Alzheimer Disease: Current Concepts

    Article • March 2012, Bentham Science Publishers

    Professor George Perry

  336. Association of Mitochondrial Signaling in Alzheimer’s Disease and Hypoxia

    Article • March 2012, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  337. Nanoparticle-iron Chelator Conjugates as Multifunctional Disease-modifying Drugs for Prevention and Treatment of Alzheimer’s Disease

    Article • March 2012, Taylor & Francis

    Professor George Perry

  338. The role of iron as a mediator of oxidative stress in Alzheimer disease

    Article • BioFactors, March 2012, Wiley

    Professor George Perry, Professor Paula I. Moreira

  339. The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons

    Article • Journal of Neuropathology & Experimental Neurology, March 2012, Oxford University Press (OUP)

    Professor George Perry

  340. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover

    Article • Free Radical Biology and Medicine, February 2012, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  341. Nuclear and mitochondrial DNA oxidation in Alzheimer's disease

    Article • Free Radical Research, January 2012, Taylor & Francis

    Professor George Perry, Professor Paula I. Moreira

  342. Neuroinflammation, Hyperphosphorylated Tau, Diffuse Amyloid Plaques, and Down-Regulation of the Cellular Prion Protein in Air Pollution Exposed Children and Young Adults

    Article • Journal of Alzheimer’s Disease, January 2012, IOS Press

    Professor George Perry

  343. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1

    Article • Human Molecular Genetics, January 2012, Oxford University Press (OUP)

    Professor George Perry

  344. The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview

    Article • International Journal of Alzheimer s Disease, January 2012, Hindawi Publishing Corporation

    Professor George Perry

  345. Pharmaceutical Regulation: Crossroad of Opportunity as the Distinction between Food and Drugs Blurs

    Article • Pharmaceutical Regulatory Affairs Open Access, January 2012, OMICS Publishing Group

    Professor George Perry

  346. Mitochondrial Importance in Alzheimer’s, Huntington’s and Parkinson’s Diseases

    Article • January 2012, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  347. Mark A. Smith: neurocytochemistry innovator

    Article • Journal of Neurochemistry, January 2012, Wiley

    Professor George Perry

  348. Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?

    Article • International Journal of Alzheimer s Disease, January 2012, Hindawi Publishing Corporation

    Professor George Perry, Professor Paula I. Moreira

  349. Editors & Editorial Board

    Article • Journal of Bioequivalence & Bioavailability, January 2012, OMICS Publishing Group

    Professor George Perry

  350. Doβ-Defensins and Other Antimicrobial Peptides Play a Role in Neuroimmune Function and Neurodegeneration?

    Article • The Scientific World JOURNAL, January 2012, Hindawi Publishing Corporation

    Professor George Perry

  351. Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer’s Disease Treatment: Rethinking the Current Strategy

    Article • International Journal of Alzheimer s Disease, January 2012, Hindawi Publishing Corporation

    Professor George Perry

  352. Alzheimer's Disease and Vascular Deficiency: Lessons from Imaging Studies and Down Syndrome

    Article • Current Gerontology and Geriatrics Research, January 2012, Hindawi Publishing Corporation

    Professor George Perry

  353. AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation

    Article • Neurobiology of Aging, January 2012, Elsevier

    Professor George Perry

  354. A Pleotrophic Age for Alzheimer and Parkinson disease

    Article • Journal of Alzheimer’s Disease & Parkinsonism, January 2012, OMICS Publishing Group

    Professor George Perry

  355. Editorial (A New Era for Medicinal Chemistry)

    Article • Mini-Reviews in Medicinal Chemistry, January 2012, Bentham Science Publishers

    Professor George Perry

  356. Thinking Outside the Box in Alzheimer Disease Treatment

    Article • December 2011, Wiley

    Professor George Perry

  357. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease

    Article • Journal of Neurochemistry, December 2011, Wiley

    Professor George Perry

  358. In Vivo and In Silico Evidence: Hippocampal Cholesterol Metabolism Decreases with Aging and Increases with Alzheimers Disease -- Modeling Brain Aging and Disease

    Article • December 2011, Institute of Electrical & Electronics Engineers (IEEE)

    Professor George Perry

  359. Intrahippocampal Amyloid-β (1-40) Injections Injure Medial Septal Neurons in Rats

    Article • Current Alzheimer Research, December 2011, Bentham Science Publishers

    Professor George Perry

  360. Amyloid-β peptide structure in aqueous solution varies with fragment size

    Article • The Journal of Chemical Physics, November 2011, American Institute of Physics

    Orkid Coskuner, Professor George Perry, Orkid Coskuner, Orkid Coskuner-Weber

  361. Cellular prion protein is essential for oligomeric amyloid- -induced neuronal cell death

    Article • Human Molecular Genetics, November 2011, Oxford University Press (OUP)

    Professor George Perry

  362. Imaging the Alzheimer Brain

    Article • Journal of Alzheimer’s Disease, October 2011, IOS Press

    Professor George Perry

  363. A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules

    Article • Laboratory Investigation, October 2011, Springer Science + Business Media

    Professor George Perry

  364. New Insights into the Mechanisms of Mitochondrial Preconditioning-Triggered Neuroprotection

    Article • Current Pharmaceutical Design, October 2011, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  365. The Mitochondrial Dynamics of Alzheimers Disease and Parkinsons Disease Offer Important Opportunities for Therapeutic Intervention

    Article • Current Pharmaceutical Design, October 2011, Bentham Science Publishers

    Professor George Perry

  366. Oxidative Stress and Balance in Neurodegenerative Diseases

    Article • September 2011, Wiley

    Professor George Perry, Professor Paula I. Moreira

  367. Mark A. Smith: The Scientist, the Man

    Article • International Journal of Experimental Pathology, September 2011, Wiley

    Professor George Perry

  368. Faculty of 1000 evaluation for Iron(II) binding to amyloid-β, the Alzheimer's peptide.

    Article • September 2011, Faculty of 1000, Ltd.

    Professor George Perry

  369. Pathological phenotype in familial neurodegenerative disease: implications for families and therapeutic constructs

    Article • Therapy, September 2011, Future Medicine

    Professor George Perry

  370. In Memoriam: Mark A. Smith, PhD

    Article • Disease-a-Month, September 2011, Elsevier

    Professor George Perry

  371. Alzheimer’s disease therapy: a moving target

    Article • Therapy, September 2011, OMICS Publishing Group

    Professor George Perry

  372. A Novel Perspective on Tau in Alzheimers Disease

    Article • Current Alzheimer Research, September 2011, Bentham Science Publishers

    Professor George Perry

  373. Neurofilamentopathy in Neurodegenerative Diseases

    Article • The Open Neurology Journal, August 2011, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  374. In Memoriam: Mark A. Smith, PhD: Neuroscientist and Visionary

    Article • Neuropathology, July 2011, Wiley

    Professor George Perry

  375. The origin of oxidative stress in neurodegenerative disease: Mark Anthony Smith 1965–2010

    Article • Free Radical Biology and Medicine, July 2011, Elsevier

    Professor George Perry

  376. The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies

    Article • Journal of Neuropathology & Experimental Neurology, July 2011, Oxford University Press (OUP)

    Professor George Perry

  377. Decline in mitochondrial bioenergetics underlies central insulin resistance in streptozocin-induced model of sporadic Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2011, Elsevier

    Professor George Perry

  378. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson’s disease

    Article • Aging Cell, June 2011, Wiley

    Professor George Perry

  379. Journal of Parkinson's Disease – Birth of JAD's New Sister

    Article • Journal of Alzheimer’s Disease, June 2011, IOS Press

    Professor George Perry

  380. Mark A. Smith, PhD: Renegade Scientist and Visionary

    Article • Journal of Neuropathology & Experimental Neurology, June 2011, Oxford University Press (OUP)

    Professor George Perry

  381. Facilitated Neurogenesis in the Developing Hippocampus After Intake of Theanine, an Amino Acid in Tea Leaves, and Object Recognition Memory

    Article • Cellular and Molecular Neurobiology, May 2011, Springer Science + Business Media

    Professor George Perry

  382. Launch of ‘Atlas Journal of Medical and Biological Sciences’

    Article • Atlas Journal of Medical and Biological Sciences, May 2011, Atlas Publishing, LP

    Professor George Perry

  383. Drug Discovery for Neurodegenerative Diseases: Challenges and Novel Biochemical Targets

    Article • Journal of Alzheimer’s Disease, April 2011, IOS Press

    Professor George Perry

  384. Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?

    Article • Ageing Research Reviews, April 2011, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  385. Mark Anthony Smith (1965–2010): Visionary, Alzheimer Researcher, and Editor-in-Chief of the Journal of Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, March 2011, IOS Press

    Professor George Perry

  386. The concept of redox balance in Alzheimer's disease: Mark Anthony Smith 1965–2010

    Article • Redox Report, March 2011, Taylor & Francis

    Professor George Perry

  387. Neurodegenerative processes in Alzheimer’s disease: an overview of pathogenesis with strategic biomarker potential

    Article • Future Neurology, March 2011, Future Medicine

    Professor George Perry

  388. Modeling cholesterol metabolism by gene expression profiling in the hippocampus

    Article • Molecular BioSystems, January 2011, Royal Society of Chemistry

    Professor George Perry

  389. Role of metal dyshomeostasis in Alzheimer's disease

    Article • Metallomics, January 2011, Oxford University Press (OUP)

    Professor George Perry

  390. Oxidative Stress in Alzheimer’s Disease: A Critical Appraisal of the Causes and the Consequences

    Article • January 2011, Springer Science + Business Media

    Professor George Perry

  391. Mark A. Smith

    Article • Alzheimer Disease & Associated Disorders, January 2011, Wolters Kluwer Health

    Professor George Perry

  392. Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer’s Disease

    Article • International Journal of Knowledge Discovery in Bioinformatics, January 2011, IGI Global

    Professor George Perry

  393. Unveiling “The Switch” from Aging to Alzheimer's Disease with the Senescence-Accelerated Mouse Model (SAMP8)

    Article • January 2011, IOS Press

    Professor George Perry

  394. Mathematical modeling of microtubule dynamics: Insights into physiology and disease

    Article • Progress in Neurobiology, December 2010, Elsevier

    Professor George Perry

  395. Upregulation of Presenilin 1 in Brains of Sporadic, Late-Onset Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, November 2010, IOS Press

    Professor George Perry

  396. Oxidative Stress and Alzheimer Disease: Mechanisms and Therapeutic Opportunities

    Article • November 2010, Springer Science + Business Media

    Professor George Perry

  397. CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease

    Article • Journal of Neural Transmission, October 2010, Springer Science + Business Media

    Professor George Perry

  398. Faculty of 1000 evaluation for The prion protein as a receptor for amyloid-beta.

    Article • October 2010, Faculty of 1000, Ltd.

    Professor George Perry

  399. Potential Role of Iron in a Mediterranean-style Diet

    Article • Archives of Neurology, October 2010, American Medical Association (AMA)

    Professor George Perry

  400. Faculty of 1000 evaluation for Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.

    Article • September 2010, Faculty of 1000, Ltd.

    Professor George Perry

  401. Faculty of 1000 evaluation for Microtubule destruction induces tau liberation and its subsequent phosphorylation.

    Article • September 2010, Faculty of 1000, Ltd.

    Professor George Perry

  402. Frontiers in Alzheimer’s disease therapeutics

    Article • Therapeutic Advances in Chronic Disease, September 2010, SAGE Publications

    Professor George Perry

  403. Oxidative stress in Alzheimer disease: A possibility for prevention

    Article • Neuropharmacology, September 2010, Elsevier

    Professor George Perry

  404. Variably protease-sensitive prionopathy: A new sporadic disease of the prion protein

    Article • Annals of Neurology, August 2010, Wiley

    Professor George Perry, Professor Piero Parchi

  405. Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

    Article • Redox Report, August 2010, Taylor & Francis

    Professor George Perry

  406. Elevation of β-Amyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment

    Article • Archives of Neurology, July 2010, American Medical Association (AMA)

    Professor George Perry

  407. Total antioxidant status in newly diagnosed Alzheimer's patients: Population based study

    Article • Alzheimer s & Dementia, July 2010, Elsevier

    Professor George Perry

  408. Paraffin-embedded tissue (PET) blot method: Application to Alzheimer disease

    Article • Journal of Neuroscience Methods, July 2010, Elsevier

    Professor George Perry

  409. Lipid peroxidation markers are associated with granulovacuolar degeneration but not lipofuscin formation

    Article • Alzheimer s & Dementia, July 2010, Elsevier

    Professor George Perry

  410. Disturbance in AMP-activated protein kinase (AMPK) signaling pathway in Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2010, Elsevier

    Professor George Perry

  411. Autophagy in Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, July 2010, Taylor & Francis

    Professor George Perry, Professor Paula I. Moreira

  412. Antioxidant approaches for the treatment of Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, July 2010, Taylor & Francis

    Professor George Perry

  413. ADF/cofilin-actin rods and synaptic loss in Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2010, Elsevier

    Professor George Perry

  414. The Importance of Histochemical Detection of Oxidative Damage in Tissue

    Article • Microscopy and Microanalysis, July 2010, Cambridge University Press

    Professor George Perry

  415. Hydroxynonenal-Generated Crosslinking Fluorophore and Mitochondria-derived Lipoic Acid Accumulation in Alzheimer Disease Reveal a Dichotomy of Protein Turnover

    Article • Microscopy and Microanalysis, July 2010, Cambridge University Press

    Professor George Perry

  416. A Synergistic Dysfunction of Mitochondrial Fission/Fusion Dynamics and Mitophagy in Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, June 2010, IOS Press

    Professor George Perry, Professor Paula I. Moreira

  417. Mitochondria and Neurodegenerative Diseases

    Article • Journal of Alzheimer’s Disease, June 2010, IOS Press

    Professor George Perry

  418. Mitochondria: The Missing Link Between Preconditioning and Neuroprotection

    Article • Journal of Alzheimer’s Disease, June 2010, IOS Press

    Professor George Perry, Professor Paula I. Moreira

  419. SU‐GG‐T‐341: Initial Results of Real‐Time External Surface Motion and Dose Monitoring Study for Lung Patients

    Article • Medical Physics, June 2010, Wiley

    Professor George Perry

  420. Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis

    Article • Expert Review of Neurotherapeutics, May 2010, Taylor & Francis

    Professor George Perry

  421. A Novel Endogenous Indole Protects Rodent Mitochondria and Extends Rotifer Lifespan

    Article • PLOS One, April 2010, PLOS

    Professor George Perry

  422. Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acid

    Article • Free Radical Research, April 2010, Taylor & Francis

    Professor George Perry

  423. Divalent metal transporter, iron and Parkinson's disease: A pathological relationship

    Article • BDJ, April 2010, Springer Science + Business Media

    Professor George Perry

  424. Prospects on the Origin of Alzheimer's disease

    Article • Journal of Alzheimer’s Disease, April 2010, IOS Press

    Professor George Perry

  425. Widespread distribution of reticulon-3 in various neurodegenerative diseases

    Article • Neuropathology, March 2010, Wiley

    Professor George Perry

  426. NMR Studies of Zinc, Copper, and Iron Binding to Histidine, the Principal Metal Ion Complexing Site of Amyloid-β Peptide

    Article • Journal of Alzheimer’s Disease, March 2010, IOS Press

    Professor George Perry

  427. William R. Markesbery, M.D.: A Tribute

    Article • Journal of Alzheimer’s Disease, March 2010, IOS Press

    Professor George Perry

  428. Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease

    Article • Neurobiology of Disease, March 2010, Elsevier

    Professor George Perry

  429. Mitochondrial Dynamics in Alzheimerʼs Disease

    Article • Drugs & Aging, March 2010, Springer Science + Business Media

    Professor George Perry

  430. Memantine

    Article • American Journal Of Pathology, February 2010, Elsevier

    Professor George Perry

  431. Biomarkers in Alzheimer’s disease: past, present and future

    Article • Biomarkers in Medicine, February 2010, Future Medicine

    Professor George Perry

  432. Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?

    Article • Molecular Neurobiology, January 2010, Springer Science + Business Media

    Professor George Perry

  433. Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment

    Article • Journal of Alzheimer’s Disease, January 2010, IOS Press

    Professor George Perry

  434. Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells

    Article • Neuroscience Letters, January 2010, Elsevier

    Professor George Perry

  435. Abnormal mitochondrial dynamics and neurodegenerative diseases

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, January 2010, Elsevier

    Professor George Perry

  436. Signaling effect of amyloid-β42 on the processing of AβPP

    Article • Experimental Neurology, January 2010, Elsevier

    Professor George Perry

  437. Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy

    Article • January 2010, Springer Science + Business Media

    Professor George Perry

  438. Mitochondrial preconditioning: a potential neuroprotective strategy

    Article • Frontiers in Aging Neuroscience, January 2010, Frontiers

    Professor George Perry, Professor Paula I. Moreira

  439. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, January 2010, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  440. Mitochondria: A therapeutic target in neurodegeneration

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, January 2010, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  441. Editors & Editorial Board

    Article • Journal of Analytical & Bioanalytical Techniques, January 2010, OMICS Publishing Group

    Professor George Perry

  442. Dissociated amyloid-β antibody levels as a serum biomarker for the progression of Alzheimer’s disease: A population-based study

    Article • Experimental Gerontology, January 2010, Elsevier

    Professor George Perry

  443. Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers

    Article • Hippocampus, January 2010, Wiley

    Professor George Perry

  444. Chapter 19. Targeting Oxidative Mechanisms in Alzheimer Disease

    Article • January 2010, Royal Society of Chemistry

    Professor George Perry

  445. Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons

    Article • Neurodegenerative Diseases, January 2010, Karger Publishers

    Professor George Perry

  446. Mitochondrial Drugs for Alzheimer Disease

    Article • Pharmaceuticals, December 2009, MDPI AG

    Professor George Perry

  447. Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets

    Article • Pharmaceuticals, December 2009, MDPI AG

    Professor George Perry, Professor Paula I. Moreira

  448. Natural Oxidant Balance in Parkinson Disease

    Article • Archives of Neurology, December 2009, American Medical Association (AMA)

    Professor George Perry, Professor Paula I. Moreira

  449. Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy

    Article • November 2009, Springer Science + Business Media

    Professor George Perry

  450. Detection and Localization of Markers of Oxidative Stress by In Situ Methods: Application in the Study of Alzheimer Disease

    Article • November 2009, Springer Science + Business Media

    Professor George Perry

  451. All-transretinoic acid as a novel therapeutic strategy for Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, November 2009, Taylor & Francis

    Professor George Perry

  452. 2009 Award Recipients-Peter C. Burger, MD, Pierluigi Gambetti, MD, and Nicholas K. Gonatas, MD

    Article • Journal of Neuropathology & Experimental Neurology, November 2009, Oxford University Press (OUP)

    Professor George Perry

  453. Insulin is a Two-Edged Knife on the Brain

    Article • Journal of Alzheimer’s Disease, October 2009, IOS Press

    Professor George Perry

  454. Evidence for Oxidative Damage in the Autistic Brain

    Article • October 2009, Taylor & Francis

    Professor George Perry

  455. Food Antioxidants and Alzheimer’s Disease

    Article • October 2009, Taylor & Francis

    Professor George Perry

  456. Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia

    Article • Journal of Bioenergetics and Biomembranes, October 2009, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  457. Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease

    Article • Neuroscience Letters, September 2009, Elsevier

    Professor George Perry

  458. Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β

    Article • Journal of Alzheimer’s Disease, August 2009, IOS Press

    Professor George Perry

  459. Preventative effect of mitochondrial antioxidants in apoe deficiency mouse model of brain hypoperfusion

    Article • Journal of the Neurological Sciences, August 2009, Elsevier

    Professor George Perry

  460. Is oxidative stress an initiator of mitochondrial failure and vascular hypoperfusion during aging and Alzheimer disease? Present and future

    Article • Journal of the Neurological Sciences, August 2009, Elsevier

    Professor George Perry

  461. Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease

    Article • Neuroscience Letters, August 2009, Elsevier

    Professor George Perry

  462. Autophagocytosis of mitochondria is prominent in Alzheimer disease

    Article • Journal of the Neurological Sciences, August 2009, Elsevier

    Professor George Perry

  463. Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

    Article • Journal of Neuroscience, July 2009, Society for Neuroscience

    Professor George Perry

  464. Hydroxynonenal generated crosslinking fluorophores accumulate in Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Professor George Perry

  465. Dissociated Aβ antibody level in newly diagnosed Alzheimer's disease: A population-based study

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Professor George Perry

  466. Tau - an inhibitor of deacetylase HDAC6 function

    Article • Journal of Neurochemistry, June 2009, Wiley

    Professor George Perry

  467. Metal Chelators Coupled with Nanoparticles as Potential Therapeutic Agents for Alzheimer's Disease

    Article • Journal of Nanoneuroscience, June 2009, American Scientific Publishers

    Professor George Perry

  468. Oxidative Stress in Parkinson`s Disease

    Article • The Open Pathology Journal, May 2009, Bentham Science Publishers

    Professor George Perry

  469. Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation

    Article • Journal of Cellular and Molecular Medicine, May 2009, Wiley

    Professor George Perry

  470. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease

    Article • Journal of Neurochemistry, May 2009, Wiley

    Professor George Perry

  471. Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease

    Article • Neuroscience Letters, May 2009, Elsevier

    Professor George Perry

  472. Getting the iron out: Phlebotomy for Alzheimer’s disease?

    Article • Medical Hypotheses, May 2009, Elsevier

    Professor George Perry

  473. Leptin: A Novel Therapeutic Strategy for Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, April 2009, IOS Press

    Professor George Perry

  474. Oxidative Stress in Diabetes and Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, April 2009, IOS Press

    Professor George Perry

  475. The Neuroscience Peer Review Consortium

    Article • The Journal of Comparative Neurology, April 2009, Wiley

    Professor George Perry, Dr. Karl Zilles

  476. A novel approach to the identification and quantitative elemental analysis of amyloid deposits—Insights into the pathology of Alzheimer’s disease

    Article • Biochemical and Biophysical Research Communications, April 2009, Elsevier

    Professor George Perry

  477. Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches

    Article • International Journal of Molecular Sciences, March 2009, MDPI AG

    Professor George Perry

  478. RNA oxidation in Alzheimer disease and related neurodegenerative disorders

    Article • Acta Neuropathologica, March 2009, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  479. The Neuroscience Peer Review Consortium

    Article • European Psychiatry, March 2009, Elsevier

    Professor George Perry, Dr. Karl Zilles

  480. The Neuroscience Peer Review Consortium

    Article • Neuropharmacology, March 2009, Elsevier

    Professor George Perry, Dr. Karl Zilles

  481. The Neuronal Expression of MYC Causes a Neurodegenerative Phenotype in a Novel Transgenic Mouse

    Article • American Journal Of Pathology, March 2009, Elsevier

    Professor George Perry

  482. The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells

    Article • Journal of Neurochemistry, March 2009, Wiley

    Professor George Perry

  483. The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α

    Article • Journal of Neurochemistry, February 2009, Wiley

    Professor George Perry

  484. Is Alzheimers Disease a Myth? When is Disease a Disease?

    Article • Current Alzheimer Research, February 2009, Bentham Science Publishers

    Professor George Perry

  485. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease

    Article • Neurochemistry International, February 2009, Elsevier

    Professor George Perry

  486. Altered redox balance in disease: Can we change the new equilibria?

    Article • Annals of Neurology, February 2009, Wiley

    Professor George Perry, Professor Paula I. Moreira

  487. Brain Composition: Age-Related Changes

    Article • January 2009, Elsevier

    Professor George Perry

  488. Alzheimer’s Disease: An Overview

    Article • January 2009, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  489. Treatment advances in Alzheimer’s disease based on the oxidative stress model

    Article • F1000 Medicine Reports, January 2009, Faculty of 1000, Ltd.

    Professor George Perry

  490. The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival

    Article • Brain Research, January 2009, Elsevier

    Professor George Perry

  491. Oxidative Stress Associated Signal Transduction Cascades in Alzheimer Disease

    Article • January 2009, Springer Science + Business Media

    Professor George Perry

  492. Neurofibrillary Tangle Formation as a Protective Response to Oxidative Stress in Alzheimer’s Disease

    Article • January 2009, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  493. Journal of Bioequivalence & Bioavailability

    Article • Journal of Bioequivalence & Bioavailability, January 2009, OMICS Publishing Group

    Professor George Perry

  494. Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease

    Article • Molecular Neurodegeneration, January 2009, Springer Science + Business Media

    Professor George Perry

  495. Development of iron chelator–nanoparticle conjugates as potential therapeutic agents for Alzheimer disease

    Article • January 2009, Elsevier

    Professor George Perry

  496. Current Hypotheses and Research Milestones in Alzheimer's Disease

    Article • January 2009, Springer Science + Business Media

    Professor George Perry

  497. Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

    Article • Free Radical Research, January 2009, Taylor & Francis

    Professor George Perry

  498. Alzheimer Disease: Oxidative Stress and Compensatory Responses

    Article • January 2009, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  499. Neuronal Cytoskeleton Regulation and Neurodegeneration

    Article • January 2009, Springer Science + Business Media

    Professor George Perry

  500. Are Amyloids Infectious?

    Article • January 2009, Springer Science + Business Media

    Professor George Perry

  501. Cerebral and Cardiac Vascular Pathology in Alzheimer’s Disease

    Article • January 2009, Springer Science + Business Media

    Professor George Perry

  502. How Biochemical Pathways for Disease May be Triggered by Early-Life Events

    Article • January 2009, Springer Science + Business Media

    Professor George Perry

  503. Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress

    Article • Zeitschrift für Ernährungswissenschaft, December 2008, Springer Science + Business Media

    Professor George Perry

  504. Oxidative Stress Signaling in Alzheimers Disease

    Article • Current Alzheimer Research, December 2008, Bentham Science Publishers

    Professor Paula I. Moreira, Professor George Perry

  505. Neuroprotective effect of cocoa flavonids on in vitro oxidative stress

    Article • Zeitschrift für Ernährungswissenschaft, November 2008, Springer Science + Business Media

    Professor George Perry

  506. Antioxidant Therapy in Alzheimers Disease: Theory and Practice

    Article • Mini-Reviews in Medicinal Chemistry, November 2008, Bentham Science Publishers

    Professor Paula I. Moreira, Professor George Perry

  507. Transgenic Mouse Models of Alzheimer's Disease

    Article • October 2008, Taylor & Francis

    Professor George Perry

  508. Faculty of 1000 evaluation for Mitochondrial fragmentation in neurodegeneration.

    Article • October 2008, Faculty of 1000, Ltd.

    Professor George Perry

  509. Alzheimer's Disease: Cerebrovascular Dysfunction, Oxidative stress, and Advanced Clinical Therapies

    Article • Journal of Alzheimer’s Disease, October 2008, IOS Press

    Professor George Perry

  510. Redox active iron accumulation in aceruloplasminemia

    Article • Neuropathology, October 2008, Wiley

    Professor George Perry

  511. Cellular Respiration and Tumor Suppressor Genes

    Article • September 2008, Springer Science + Business Media

    Professor George Perry

  512. Faculty of 1000 evaluation for The amyloid cascade hypothesis.

    Article • September 2008, Faculty of 1000, Ltd.

    Professor George Perry

  513. Faculty of 1000 evaluation for Prediction of aggregation-prone regions in structured proteins.

    Article • September 2008, Faculty of 1000, Ltd.

    Professor George Perry

  514. Faculty of 1000 evaluation for Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease.

    Article • September 2008, Faculty of 1000, Ltd.

    Professor George Perry

  515. Faculty of 1000 evaluation for Amyloid precursor protein expression is upregulated in adipocytes in obesity.

    Article • September 2008, Faculty of 1000, Ltd.

    Professor George Perry

  516. Antigenantibody dissociation in Alzheimer disease: a novel approach to diagnosis

    Article • Journal of Neurochemistry, August 2008, Wiley

    Professor George Perry

  517. Neuronal binucleation in Alzheimer disease hippocampus

    Article • Neuropathology and Applied Neurobiology, August 2008, Wiley

    Professor George Perry

  518. Phosphorylated Tau: Toxic, Protective, or None of the Above

    Article • Journal of Alzheimer’s Disease, July 2008, IOS Press

    Professor George Perry

  519. Upcoming Meetings Related to Alzheimer's Disease*

    Article • Journal of Alzheimer’s Disease, July 2008, IOS Press

    Professor George Perry

  520. Is Tau Aggregation Toxic or Protective?

    Article • Journal of Alzheimer’s Disease, July 2008, IOS Press

    Professor George Perry

  521. Is Tau Aggregation Toxic or Protective?

    Article • Journal of Alzheimer’s Disease, July 2008, IOS Press

    Professor George Perry

  522. Stem cell niches as clinical targets: the future of anti-ischemic therapy?

    Article • Nature Clinical Practice Neurology, July 2008, Springer Science + Business Media

    Professor George Perry

  523. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease

    Article • Journal of Neurochemistry, July 2008, Wiley

    Professor George Perry

  524. P4-171: Cerebral hypoperfusion-induced oxidative stress and mitochondrial failure as initiators of aging and Alzheimer's disease pathology

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor George Perry

  525. P4-166: Overexpression of amyloid precursor protein causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor George Perry

  526. P3-317: Failure in the control of cell cycle causes neurodegeneration

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor George Perry

  527. P1-351: A novel approach to diagnosis: Antigen-antibody disassociation in Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Professor George Perry

  528. Nonestrogen-based hormonal therapies for Alzheimer’s disease

    Article • Future Neurology, July 2008, Future Medicine

    Professor George Perry

  529. Cerebrotendinous xanthomatosis: a critical update

    Article • Future Neurology, July 2008, Future Medicine

    Professor George Perry

  530. Three-Dimensional Tomographic Imaging and Characterization of Iron Compounds within Alzheimer's Plaque Core Material

    Article • Journal of Alzheimer’s Disease, June 2008, IOS Press

    Professor George Perry

  531. Alzheimer Disease Pathology As a Host Response

    Article • Journal of Neuropathology & Experimental Neurology, June 2008, Oxford University Press (OUP)

    Professor George Perry

  532. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease

    Article • Vascular Health and Risk Management, June 2008, Taylor & Francis

    Professor George Perry

  533. Antibodies to Potato Virus Y Bind the Amyloid   Peptide: IMMUNOHISTOCHEMICAL AND NMR STUDIES

    Article • Journal of Biological Chemistry, May 2008, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor George Perry

  534. Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease

    Article • International Journal of Molecular Sciences, May 2008, MDPI AG

    Professor George Perry, Professor Paula I. Moreira

  535. Faculty of 1000 evaluation for N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.

    Article • May 2008, Faculty of 1000, Ltd.

    Professor George Perry

  536. Faculty of 1000 evaluation for Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.

    Article • May 2008, Faculty of 1000, Ltd.

    Professor George Perry

  537. DOES THE OXIDATIVE STRESS AND CEREBRAL ATHEROSCLEROSIS INITIATE BRAIN HYPOPERFUSION AND THE DEVELOPMENT OF ALZHEIMER DISEASE?

    Article • Atherosclerosis Supplements, May 2008, Elsevier

    Professor George Perry

  538. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes

    Article • AGE, April 2008, Springer Science + Business Media

    Professor George Perry

  539. Faculty of 1000 evaluation for Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers.

    Article • April 2008, Faculty of 1000, Ltd.

    Professor George Perry

  540. Nucleic acid oxidation in Alzheimer disease

    Article • Free Radical Biology and Medicine, April 2008, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  541. Current approaches in the treatment of Alzheimer's disease

    Article • Biomedicine & Pharmacotherapy, April 2008, Elsevier

    Professor George Perry

  542. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats

    Article • Journal of Cellular and Molecular Medicine, March 2008, Wiley

    Professor George Perry

  543. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease

    Article • International Journal of Experimental Pathology, March 2008, Wiley

    Professor George Perry

  544. The primary pathogenetic role of vascular hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease

    Article • The FASEB Journal, March 2008, Wiley

    Professor George Perry

  545. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

    Article • Autophagy, February 2008, Taylor & Francis

    Professor Gianluca Tettamanti, Dr Takeshi Noda, Professor George Perry, Professor Brigitte Galliot, Professor Nektarios Tavernarakis

  546. Physiological regulation of tau phosphorylation during hibernation

    Article • Journal of Neurochemistry, February 2008, Wiley

    Professor George Perry

  547. Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease

    Article • CNS & Neurological Disorders - Drug Targets, February 2008, Bentham Science Publishers

    Professor Paula I. Moreira, Professor George Perry

  548. Oxidative Stress and Neurotoxicity

    Article • Chemical Research in Toxicology, January 2008, American Chemical Society (ACS)

    Professor George Perry

  549. Menopause, Estrogen, and Gonadotropins in Alzheimer's Disease

    Article • January 2008, Elsevier

    Professor George Perry

  550. Leucine-Rich Repeat Kinase 2 Colocalizes with α-Synuclein in Parkinson’s Disease, but Not Tau-Containing Deposits in Tauopathies

    Article • Neurodegenerative Diseases, January 2008, Karger Publishers

    Professor George Perry

  551. Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease

    Article • Molecular Neurodegeneration, January 2008, Springer Science + Business Media

    Professor George Perry

  552. A New Model of Oxidative Stress in Rat Pups

    Article • Neonatology, January 2008, Karger Publishers

    Professor George Perry

  553. Protein Misfolding in Alzheimer's Disease

    Article • December 2007, Taylor & Francis

    Professor George Perry

  554. Neuronal Death and Survival Under Oxidative Stress in Alzheimer and Parkinson Diseases

    Article • CNS & Neurological Disorders - Drug Targets, December 2007, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  555. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide

    Article • Free Radical Biology and Medicine, December 2007, Elsevier

    Professor George Perry

  556. Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia

    Article • Redox Report, December 2007, Taylor & Francis

    Professor George Perry

  557. Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease

    Article • Free Radical Biology and Medicine, December 2007, Elsevier

    Professor George Perry

  558. Evidence for the Role of Luteinizing Hormone in Alzheimer Disease

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, December 2007, Bentham Science Publishers

    Professor George Perry

  559. Oxidative RNA Damage and Neurodegeneration

    Article • Current Medicinal Chemistry, December 2007, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  560. The role of novel chitin-like polysaccharides in Alzheimer disease

    Article • Neurotoxicity Research, December 2007, Springer Science + Business Media

    Professor George Perry

  561. Increased Autophagic Degradation of Mitochondria in Alzheimer Disease

    Article • Autophagy, November 2007, Taylor & Francis

    Professor George Perry

  562. Oxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor protein

    Article • Journal of Neurochemistry, November 2007, Wiley

    Professor George Perry

  563. Three Histidine Residues of Amyloid-β Peptide Control the Redox Activity of Copper and Iron

    Article • Biochemistry, November 2007, American Chemical Society (ACS)

    Professor George Perry

  564. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology

    Article • Neuropathology and Applied Neurobiology, October 2007, Wiley

    Professor George Perry

  565. Faculty of 1000 evaluation for Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

    Article • October 2007, Faculty of 1000, Ltd.

    Professor George Perry

  566. The Contribution of Luteinizing Hormone to Alzheimer Disease Pathogenesis

    Article • Clinical Medicine & Research, October 2007, Marshfield Clinic Research Foundation

    Professor George Perry

  567. Oxidative Stress Is an Early Event in Hydrostatic Pressure–Induced Retinal Ganglion Cell Damage

    Article • Investigative Ophthalmology & Visual Science, October 2007, Association for Research in Vision and Ophthalmology (ARVO)

    Professor George Perry

  568. Lipoic Acid and N-acetyl Cysteine Decrease Mitochondrial-Related Oxidative Stress in Alzheimer Disease Patient Fibroblasts

    Article • Journal of Alzheimer’s Disease, September 2007, IOS Press

    Professor George Perry

  569. Nanoparticles for the Treatment of Alzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives

    Article • September 2007, Wiley

    Professor George Perry

  570. Faculty of 1000 evaluation for Time resolved structure analysis of growing beta-amyloid fibers.

    Article • September 2007, Faculty of 1000, Ltd.

    Professor George Perry

  571. Faculty of 1000 evaluation for Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases.

    Article • September 2007, Faculty of 1000, Ltd.

    Professor George Perry

  572. Olfactory dysfunction in Parkinson's disease

    Article • Deutsche Zeitschrift für Nervenheilkunde, August 2007, Springer Science + Business Media

    Professor George Perry

  573. Causes of oxidative stress in Alzheimer disease

    Article • Cellular and Molecular Life Sciences, July 2007, Springer Science + Business Media

    Professor George Perry

  574. Errata

    Article • Journal of Neuropathology & Experimental Neurology, July 2007, Oxford University Press (OUP)

    Professor George Perry, Professor Paula I. Moreira

  575. Autophagocytosis of Mitochondria Is Prominent in Alzheimer Disease

    Article • Journal of Neuropathology & Experimental Neurology, June 2007, Oxford University Press (OUP)

    Professor George Perry, Professor Paula I. Moreira

  576. Vascular oxidative stress in Alzheimer disease

    Article • Journal of the Neurological Sciences, June 2007, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  577. Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress

    Article • Redox Report, June 2007, Taylor & Francis

    Professor George Perry

  578. c-Jun phosphorylation in Alzheimer disease

    Article • Journal of Neuroscience Research, June 2007, Wiley

    Professor George Perry

  579. PO13-357 THE PRIMARY PATHOGENETIC ROLE OF VASCULAR HYPOPERFUSION, AND OXIDATIVE STRESS IN ALZHEIMER DISEASE

    Article • Atherosclerosis Supplements, June 2007, Elsevier

    Professor George Perry

  580. Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease

    Article • Neurochemical Research, May 2007, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  581. Signal Transduction Cascades Associated with Oxidative Stress in Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, May 2007, IOS Press

    Professor George Perry

  582. Treating the Lesions, Not the Disease

    Article • American Journal Of Pathology, May 2007, Elsevier

    Professor George Perry

  583. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?

    Article • Expert Review of Neurotherapeutics, May 2007, Taylor & Francis

    Professor George Perry, Professor Paula I. Moreira

  584. Lipoic acid and N-acetyl cysteine protect against mitochondrial-related oxidative stress in fibroblasts from Alzheimer disease patients

    Article • Journal of Neuropathology & Experimental Neurology, May 2007, Oxford University Press (OUP)

    Professor George Perry

  585. Mitochondrial autophagocytosis in Alzheimer disease

    Article • Journal of Neuropathology & Experimental Neurology, May 2007, Oxford University Press (OUP)

    Professor George Perry

  586. Faculty of 1000 evaluation for Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry.

    Article • April 2007, Faculty of 1000, Ltd.

    Professor George Perry

  587. Faculty of 1000 evaluation for Oxidative stress mediates tau-induced neurodegeneration in Drosophila.

    Article • April 2007, Faculty of 1000, Ltd.

    Professor George Perry

  588. Increases in luteinizing hormone are associated with declines in cognitive performance

    Article • Molecular and Cellular Endocrinology, April 2007, Elsevier

    Professor George Perry

  589. Alzheimer disease, the two-hit hypothesis: An update

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, April 2007, Elsevier

    Professor George Perry

  590. Mitochondrial Autophagocytosis in Alzheimer Disease

    Article • The FASEB Journal, April 2007, Wiley

    Professor George Perry

  591. Indices of Metabolic Dysfunction and Oxidative Stress

    Article • Neurochemical Research, March 2007, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  592. Sir Martin Roth – A Debt of Gratitude

    Article • Journal of Alzheimer’s Disease, March 2007, IOS Press

    Professor George Perry

  593. Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants

    Article • Mini-Reviews in Medicinal Chemistry, February 2007, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  594. Increased Expression of the Remodeling- and Tumorigenic-Associated Factor Osteopontin in Pyramidal Neurons of the Alzheimers Disease Brain

    Article • Current Alzheimer Research, February 2007, Bentham Science Publishers

    Professor George Perry

  595. Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses

    Article • Journal of Pharmacology and Experimental Therapeutics, January 2007, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor George Perry

  596. Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolites

    Article • FEBS Letters, January 2007, Wiley

    Professor George Perry

  597. The Role of Oxidative Damage to Nucleic Acids in the Pathogenesis of Neurological Disease

    Article • January 2007, Springer Science + Business Media

    Professor George Perry

  598. The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics

    Article • January 2007, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  599. The Pathology of Alzheimer Disease Elicits an In Vivo Immunological Response

    Article • American Journal of Immunology, January 2007, Science Publications

    Professor George Perry

  600. The Key Role of Oxidative Stress in Alzheimer's Disease

    Article • January 2007, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  601. Prospects for Antioxidant Therapy in Mild Cognitive Impairment and Alzheimer's Disease

    Article • January 2007, Elsevier

    Professor George Perry

  602. Article • Molecular Neurodegeneration, January 2007, Springer Science + Business Media

    Professor George Perry

  603. Gonadotropins: A cohesive gender-based etiology of Alzheimer disease

    Article • Molecular and Cellular Endocrinology, January 2007, Elsevier

    Professor George Perry

  604. Advanced Maillard Reaction End Products, Free Radicals, and Protein Oxidation in Alzheimer's Diseasea

    Article • Annals of the New York Academy of Sciences, December 2006, Wiley

    Professor George Perry

  605. Malignant glioma progression and nitric oxide

    Article • Neurochemistry International, December 2006, Elsevier

    Professor George Perry

  606. Aberrant localization of importin α1 in hippocampal neurons in Alzheimer disease

    Article • Brain Research, December 2006, Elsevier

    Professor George Perry

  607. LRRK2 protein is a component of lewy bodies

    Article • Annals of Neurology, November 2006, Wiley

    Professor George Perry

  608. Clusterin up-regulation following sub-lethal oxidative stress and lipid peroxidation in human neuroblastoma cells

    Article • Neurobiology of Aging, November 2006, Elsevier

    Professor George Perry

  609. Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance

    Article • Neuroscience Letters, October 2006, Elsevier

    Professor George Perry

  610. Commentary on “Perspective on a pathogenesis and treatment of Alzheimer’s disease.” Therapeutic strategies for Alzheimer’s disease: The need for a new era of innovation

    Article • Alzheimer s & Dementia, October 2006, Elsevier

    Professor George Perry

  611. Increased Expression of p130 in Alzheimer Disease

    Article • Neurochemical Research, September 2006, Springer Science + Business Media

    Professor George Perry

  612. Synaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms

    Article • Journal of Cellular and Molecular Medicine, September 2006, Wiley

    Professor George Perry

  613. Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases

    Article • Current Alzheimer Research, September 2006, Bentham Science Publishers

    Professor George Perry

  614. Apoptosis in Alzheimer Disease: A Mathematical Improbability

    Article • Current Alzheimer Research, September 2006, Bentham Science Publishers

    Professor George Perry

  615. Amyloid-β Vaccination: Testing the Amyloid Hypothesis?

    Article • American Journal Of Pathology, September 2006, Elsevier

    Professor George Perry

  616. Solving the insoluble

    Article • Journal of Alzheimer’s Disease, July 2006, IOS Press

    Professor George Perry

  617. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease

    Article • Journal of Alzheimer’s Disease, July 2006, IOS Press

    Professor George Perry

  618. Synaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms

    Article • Journal of Cellular and Molecular Medicine, July 2006, Wiley

    Professor Diego A Forero, Professor George Perry

  619. Involvement of Oxidative Stress in Alzheimer Disease

    Article • Journal of Neuropathology & Experimental Neurology, July 2006, Oxford University Press (OUP)

    Professor George Perry, Professor Paula I. Moreira

  620. Emerging evidence for the neuroprotective role of α-synuclein

    Article • Experimental Neurology, July 2006, Elsevier

    Professor George Perry

  621. Telomeres and telomerase in Alzheimer’s disease: Epiphenomena or a new focus for therapeutic strategy?

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  622. P4-162

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor George Perry

  623. P3-375

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor George Perry

  624. P3-296

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor George Perry

  625. P3-369

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor George Perry

  626. P3-372

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor George Perry

  627. P1-388

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor George Perry

  628. P1-417

    Article • Alzheimer s & Dementia, July 2006, Elsevier

    Professor George Perry

  629. Amyloid-β, BACE, and oxidative stress in Alzheimer's disease, a commentary on “The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression”

    Article • Free Radical Biology and Medicine, July 2006, Elsevier

    Professor George Perry

  630. Therapeutic options in Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, June 2006, Taylor & Francis

    Professor George Perry, Professor Paula I. Moreira

  631. The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease

    Article • Mechanisms of Ageing and Development, June 2006, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  632. Neuropathology in Alzheimer's Disease: Awaking from a Hundred-Year-Old Dream

    Article • Science of Aging Knowledge Environment, May 2006, American Association for the Advancement of Science

    Professor George Perry, Professor Paula I. Moreira

  633. LC-MS display of the total modified amino acids in cataract lens proteins and in lens proteins glycated by ascorbic acid in vitro

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, May 2006, Elsevier

    Professor George Perry

  634. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic

    Article • Acta Neuropathologica, April 2006, Springer Science + Business Media

    Professor George Perry

  635. The Role of Oxidative Stress in the Pathophysiology of Cerebrovascular Lesions in Alzheimer's Disease

    Article • Brain Pathology, April 2006, Wiley

    Professor George Perry

  636. Will Preventing Protein Aggregates Live Up to Its Promise as Prophylaxis Against Neurodegenerative Diseases?

    Article • Brain Pathology, April 2006, Wiley

    Professor George Perry

  637. Luteinizing hormone modulates cognition and amyloid-β deposition in Alzheimer APP transgenic mice

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, April 2006, Elsevier

    Professor George Perry

  638. α-Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson's disease

    Article • FEBS Letters, March 2006, Wiley

    Professor George Perry

  639. Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathy

    Article • AGE, March 2006, Springer Science + Business Media

    Professor George Perry

  640. Presenilin mutation: A deadly first hit in Alzheimer disease

    Article • Free Radical Biology and Medicine, March 2006, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  641. Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau

    Article • American Journal of Alzheimer s Disease & Other Dementias®, March 2006, SAGE Publications

    Professor George Perry

  642. Amyloid Beta: The Alternate Hypothesis

    Article • Current Alzheimer Research, February 2006, Bentham Science Publishers

    Professor George Perry

  643. The Cell Cycle and Hormonal Fluxes in Alzheimer Disease: A Novel Therapeutic Target

    Article • Current Pharmaceutical Design, February 2006, Bentham Science Publishers

    Professor George Perry

  644. Arson: Tracking the Culprit in Alzheimer's Disease

    Article • Annals of the New York Academy of Sciences, January 2006, Wiley

    Professor George Perry

  645. Brain and brawn

    Article • Neurology, January 2006, Wolters Kluwer Health

    Professor George Perry

  646. The Estrogen Myth

    Article • Drugs in R&D, January 2006, Springer Science + Business Media

    Professor George Perry

  647. Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment

    Article • Journal of Biomedicine and Biotechnology, January 2006, Hindawi Publishing Corporation

    Professor George Perry

  648. Article • Molecular Neurodegeneration, January 2006, Springer Science + Business Media

    Professor George Perry

  649. Neurogenesis in Human Hippocampus: Implications for Alzheimer Disease Pathogenesis

    Article • Neuroembryology and Aging, January 2006, Karger Publishers

    Professor George Perry

  650. Neurodegenerative Diseases: Mechanisms and Therapies

    Article • Journal of Biomedicine and Biotechnology, January 2006, Hindawi Publishing Corporation

    Professor George Perry

  651. Article • Molecular Neurodegeneration, January 2006, Springer Science + Business Media

    Professor George Perry

  652. Heme Deficiency in Alzheimer’s Disease: A Possible Connection to Porphyria

    Article • Journal of Biomedicine and Biotechnology, January 2006, Hindawi Publishing Corporation

    Professor George Perry

  653. Ectopic expression of phospho-Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor-β pathway?

    Article • Journal of Neuroscience Research, January 2006, Wiley

    Professor George Perry

  654. Oxidative Damage to RNA in Neurodegenerative Diseases

    Article • Journal of Biomedicine and Biotechnology, January 2006, Hindawi Publishing Corporation

    Professor George Perry

  655. Compensatory responses induced by oxidative stress in Alzheimer disease

    Article • Biological Research, January 2006, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    Professor George Perry, Professor Paula I. Moreira

  656. The Fallacy of Amyloid and Cognition in Alzheimer???s Disease

    Article • Drugs & Aging, January 2006, Springer Science + Business Media

    Professor George Perry

  657. Therapeutic potential of oxidative stress reduction in Alzheimer's disease

    Article • Future Neurology, December 2005, Taylor & Francis

    Professor George Perry

  658. Oxidative Adaptation in Aging and Alzheimer’s Disease

    Article • November 2005, Taylor & Francis

    Professor George Perry

  659. Temporal Primacy of Oxidative Stress in the Pathological Cascade of Alzheimer Disease

    Article • November 2005, Taylor & Francis

    Professor George Perry

  660. Antioxidant Therapies in the Prevention and Treatment of Alzheimer Disease

    Article • November 2005, Taylor & Francis

    Professor George Perry

  661. Amyloid- _ and _ in Alzheimer’s Disease

    Article • November 2005, Taylor & Francis

    Professor George Perry

  662. Faculty of 1000 evaluation for The use of memantine in dementia with Lewy bodies.

    Article • November 2005, Faculty of 1000, Ltd.

    Professor George Perry

  663. Faculty of 1000 evaluation for The most infectious prion protein particles.

    Article • November 2005, Faculty of 1000, Ltd.

    Professor George Perry

  664. Faculty of 1000 evaluation for Alzheimer disease beta-amyloid activity mimics cholesterol oxidase.

    Article • November 2005, Faculty of 1000, Ltd.

    Professor George Perry

  665. The cell cycle in Alzheimer disease: A unique target for neuropharmacology

    Article • Mechanisms of Ageing and Development, October 2005, Elsevier

    Professor George Perry

  666. Oxidative Stress: The Old Enemy in Alzheimers Disease Pathophysiology

    Article • Current Alzheimer Research, October 2005, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  667. Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers

    Article • Molecular and Cellular Biochemistry, October 2005, Springer Science + Business Media

    Professor George Perry

  668. Chitin-like Polysaccharides in Alzheimers Disease Brains

    Article • Current Alzheimer Research, October 2005, Bentham Science Publishers

    Professor George Perry

  669. Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease

    Article • Letters in Drug Design & Discovery, September 2005, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  670. Nanoparticle and other metal chelation therapeutics in Alzheimer disease

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, September 2005, Elsevier

    Professor George Perry

  671. Alzheimer's disease: an intracellular movement disorder?

    Article • Trends in Molecular Medicine, September 2005, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  672. Redox metals and oxidative abnormalities in human prion diseases

    Article • Acta Neuropathologica, August 2005, Springer Science + Business Media

    Professor George Perry, Prof. Herbert Budka, Professor Paula I. Moreira, Mark Smith

  673. Faculty of 1000 evaluation for Alpha-synuclein alters proteasome function, protein synthesis, and stationary phase viability.

    Article • August 2005, Faculty of 1000, Ltd.

    Professor George Perry

  674. 4-Oxo-2-nonenal Is Both More Neurotoxic and More Protein Reactive than 4-Hydroxy-2-nonenal

    Article • Chemical Research in Toxicology, August 2005, American Chemical Society (ACS)

    Professor George Perry

  675. Faculty of 1000 evaluation for Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

    Article • July 2005, Faculty of 1000, Ltd.

    Professor George Perry

  676. The primary pathogenetic role of vascular contains vasoactive substances, hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease

    Article • Alzheimer s & Dementia, July 2005, Elsevier

    Professor George Perry

  677. Commentary: “Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer’s disease. Just hypotheses or molecular pathways to be identified?” By Claudio Costantini, Rekha M.K. Kolasani, and Luigi Puglielli

    Article • Alzheimer s & Dementia, July 2005, Elsevier

    Professor George Perry

  678. Ferric Cycle Activity and Alzheimer Disease

    Article • Current Neurovascular Research, July 2005, Bentham Science Publishers

    Professor George Perry

  679. Oxidative Stress and Neurodegeneration

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    Professor George Perry, Professor Paula I. Moreira

  680. P38 Activation Mediates Amyloid-β Cytotoxicity

    Article • Neurochemical Research, June 2005, Springer Science + Business Media

    Professor George Perry

  681. Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    Professor George Perry

  682. Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, June 2005, Elsevier

    Professor George Perry

  683. Role of Amyloid-β in Alzheimer's Disease

    Article • International Journal of Experimental Pathology, May 2005, Wiley

    Professor George Perry

  684. The End of a Chilean Institute

    Article • Science, May 2005, American Association for the Advancement of Science

    Professor George Perry

  685. Carnosine: A Versatile Antioxidant and Antiglycating Agent

    Article • Science of Aging Knowledge Environment, May 2005, American Association for the Advancement of Science

    Professor George Perry

  686. Therapeutic Opportunities in Alzheimer Disease: One for all or all for One?

    Article • Current Medicinal Chemistry, May 2005, Bentham Science Publishers

    Professor George Perry, Professor Paula I. Moreira

  687. Raffinee in the Treatment of Spinal Cord Injury: An Open-Labeled Clinical Trial

    Article • Annals of the New York Academy of Sciences, May 2005, Wiley

    Professor George Perry, Hung-Yi Chuang

  688. Chronological primacy of oxidative stress in Alzheimer disease

    Article • Neurobiology of Aging, May 2005, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  689. Faculty of 1000 evaluation for Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction.

    Article • April 2005, Faculty of 1000, Ltd.

    Professor George Perry

  690. Tau phosphorylation in Alzheimer's disease: pathogen or protector?

    Article • Trends in Molecular Medicine, April 2005, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  691. Nuclear microscopy of diffuse plaques in the brains of transgenic mice

    Article • Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms, April 2005, Elsevier

    Professor George Perry

  692. Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron

    Article • Journal of Biological Chemistry, March 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor George Perry, Professor Paula I. Moreira

  693. Ciprofloxacin Does Not Exert Nephrotoxicity in Rats

    Article • American Journal of Infectious Diseases, March 2005, Science Publications

    Professor George Perry

  694. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations

    Article • Free Radical Biology and Medicine, March 2005, Elsevier

    Professor George Perry, Professor Paula I. Moreira

  695. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease

    Article • Journal of the Neurological Sciences, March 2005, Elsevier

    Professor George Perry

  696. Alzheimers Disease and Oxidative Stress: The Old Problem Remains Unsolved

    Article • Current Medicinal Chemistry - Central Nervous System Agents, March 2005, Bentham Science Publishers

    Professor George Perry

  697. Faculty of 1000 evaluation for The potential role of tau protein O-glycosylation in Alzheimer's disease.

    Article • March 2005, Faculty of 1000, Ltd.

    Professor George Perry

  698. Faculty of 1000 evaluation for Oxygen causes cell death in the developing brain.

    Article • February 2005, Faculty of 1000, Ltd.

    Professor George Perry

  699. Faculty of 1000 evaluation for Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology.

    Article • February 2005, Faculty of 1000, Ltd.

    Professor George Perry

  700. Faculty of 1000 evaluation for Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.

    Article • February 2005, Faculty of 1000, Ltd.

    Professor George Perry

  701. Faculty of 1000 evaluation for Interaction of Tau with Fe65 links tau to APP.

    Article • February 2005, Faculty of 1000, Ltd.

    Professor George Perry

  702. Faculty of 1000 evaluation for Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation.

    Article • February 2005, Faculty of 1000, Ltd.

    Professor George Perry

  703. beta-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways

    Article • Journal of Neurochemistry, February 2005, Wiley

    Professor George Perry

  704. Alzheimer?s disease: the impact of age-related changes in reproductive hormones

    Article • Cellular and Molecular Life Sciences, February 2005, Springer Science + Business Media

    Professor George Perry

  705. Tau modifiers as therapeutic targets for Alzheimer's disease

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, January 2005, Elsevier

    Professor George Perry

  706. Oxidative Imbalance in Alzheimer's Disease

    Article • Molecular Neurobiology, January 2005, Springer Science + Business Media

    Professor George Perry

  707. Oxidative damage and Alzheimer's disease: Are antioxidant therapies useful?

    Article • Drug News & Perspectives, January 2005, Prous Science

    Professor George Perry

  708. Mitogen- and stress-activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease

    Article • Journal of Neuroscience Research, January 2005, Wiley

    Professor George Perry, Professor Paula I. Moreira

  709. MAPKs are differentially modulated in arctic ground squirrels during hibernation

    Article • Journal of Neuroscience Research, January 2005, Wiley

    Professor George Perry

  710. Introduction: Imaging in Alzheimer's disease

    Article • Microscopy Research and Technique, January 2005, Wiley

    Professor George Perry

  711. Concealment of epitope by reduction and alkylation in prion protein

    Article • Biochemical and Biophysical Research Communications, January 2005, Elsevier

    Professor George Perry

  712. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease

    Article • Journal of Neural Transmission, December 2004, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  713. Neurofilament proteins in neurodegenerative diseases

    Article • Cellular and Molecular Life Sciences, December 2004, Springer Science + Business Media

    Professor George Perry, Professor Paula I. Moreira

  714. Therapeutic potential of oxidant mechanisms in Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, November 2004, Taylor & Francis

    Professor George Perry, Professor Paula I. Moreira

  715. Mitochondrial failures in Alzheimer's disease

    Article • American Journal of Alzheimer s Disease & Other Dementias®, November 2004, SAGE Publications

    Professor George Perry

  716. Staying Connected

    Article • American Journal Of Pathology, November 2004, Elsevier

    Professor George Perry

  717. Faculty of 1000 evaluation for RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice.

    Article • October 2004, Faculty of 1000, Ltd.

    Professor George Perry

  718. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease

    Article • Neurobiology of Disease, October 2004, Elsevier

    Professor George Perry

  719. Symposium

    Article • Brain Pathology, October 2004, Wiley

    Professor George Perry

  720. Heme Catabolism and Heme Oxygenase in Neurodegenerative Disease

    Article • Antioxidants & Redox Signaling, October 2004, Mary Ann Liebert Inc

    Professor George Perry

  721. Faculty of 1000 evaluation for Kinetic control of dimer structure formation in amyloid fibrillogenesis.

    Article • September 2004, Faculty of 1000, Ltd.

    Professor George Perry

  722. Faculty of 1000 evaluation for Mild cognitive impairment as a diagnostic entity.

    Article • September 2004, Faculty of 1000, Ltd.

    Professor George Perry

  723. Faculty of 1000 evaluation for Systemic catabolism of Alzheimer's Abeta40 and Abeta42.

    Article • September 2004, Faculty of 1000, Ltd.

    Professor George Perry

  724. Faculty of 1000 evaluation for A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis.

    Article • September 2004, Faculty of 1000, Ltd.

    Professor George Perry

  725. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease

    Article • Mitochondrion, September 2004, Elsevier

    Professor George Perry

  726. Faculty of 1000 evaluation for Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains.

    Article • August 2004, Faculty of 1000, Ltd.

    Professor George Perry

  727. Faculty of 1000 evaluation for Formation of amyloid fibers triggered by phosphatidylserine-containing membranes.

    Article • August 2004, Faculty of 1000, Ltd.

    Professor George Perry

  728. Faculty of 1000 evaluation for Targeting prion amyloid deposits in vivo.

    Article • August 2004, Faculty of 1000, Ltd.

    Professor George Perry

  729. Faculty of 1000 evaluation for Degradation of BACE by the ubiquitin-proteasome pathway.

    Article • August 2004, Faculty of 1000, Ltd.

    Professor George Perry

  730. Beyond Estrogen: Targeting Gonadotropin Hormones in the Treatment of Alzheimers Disease

    Article • Current Drug Targets - CNS & Neurological Disorders, August 2004, Bentham Science Publishers

    Professor George Perry

  731. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease

    Article • Ageing Research Reviews, July 2004, Elsevier

    Professor George Perry

  732. Accelerated α-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells

    Article • Brain Research, July 2004, Elsevier

    Professor George Perry

  733. S4-02-01 Alzheimer disease: the two hit hypothesis

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  734. P4-250 Redox-active iron oxidizes ribosomal RNa in neurons vulnerable to Alzheimer's disease

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  735. P4-242 Oxidative damage in ferritin-induced neurodegeneration

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  736. P3-306 Differential expression of metabotrophic glutamate receptors (MGlurs) in Alzheimer disease

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  737. P3-275 Phosphorylation dependent control of oxidative modification in Alzheimer disease

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  738. P3-219 Acetylation: a novel posttranslational modification in Alzheimer disease

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  739. P2-003 Cholesterol feeding enhances cerebral amyloid beta pathology in beagles

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  740. P1-369 Modulation of cognition and amyloid load in the aged SWAβPP transgenic mouse by luprolide acetate, a GNRH agonist: targeting luteinizing hormone as a novel treatment for AD

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  741. P1-286 Glycogen synthase kinase-3β activity is regulated by products of lipid peroxidation: relevance to Alzheimer disease

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  742. P1-266 The critical role of the ERK pathway in the pathogenesis of Alzheimer's disease

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  743. O3-04-07 Vascular and metabolic failure in Alzheimer disease

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  744. O2-04-07 Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1 associated regulator of cyclin B, in Alzheimer disease

    Article • Neurobiology of Aging, July 2004, Elsevier

    Professor George Perry

  745. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?

    Article • Neurological Research, July 2004, Taylor & Francis

    Professor George Perry

  746. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells

    Article • Journal of Neurochemistry, June 2004, Wiley

    Professor George Perry

  747. Neuroprotective properties of Bcl-w in Alzheimer disease

    Article • Journal of Neurochemistry, June 2004, Wiley

    Professor George Perry

  748. In Situ Localization of Nonenzymatic Peroxidase-Like Activity of Tissue-Bound Transition Metals

    Article • June 2004, Wiley

    Professor George Perry

  749. Homocysteine and Alzheimer's disease: a modifiable risk?

    Article • Free Radical Biology and Medicine, June 2004, Elsevier

    Professor George Perry

  750. Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid-β as Protective Adaptations to Alzheimer Disease

    Article • Annals of the New York Academy of Sciences, June 2004, Wiley

    Professor George Perry

  751. VASCULAR HYPOPERFUSION AND MITOCHONDRIA ABNORMALITY INDUCE OXIDATIVE STRESS THAT APPEARED TO BE A KEY FACTOR FOR THE DEVELOPMENT OF ALZHEIMER DISEASE

    Article • Cardiovascular Pathology, May 2004, Elsevier

    Professor George Perry

  752. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesis

    Article • Neurobiology of Aging, May 2004, Elsevier

    Professor George Perry

  753. Assembly In Vitro of Tau Protein and its Implications in Alzheimers Disease

    Article • Current Alzheimer Research, May 2004, Bentham Science Publishers

    Professor George Perry

  754. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice

    Article • The Journal of Pathology, April 2004, Wiley

    Professor George Perry

  755. Perspectives on the Amyloid-β Cascade Hypothesis

    Article • Journal of Alzheimer’s Disease, April 2004, IOS Press

    Professor George Perry

  756. Oxidative stress signalling in Alzheimer's disease

    Article • Brain Research, March 2004, Elsevier

    Professor George Perry

  757. Oxidative Stress and Redox-Active Iron in Alzheimer's Disease

    Article • Annals of the New York Academy of Sciences, March 2004, Wiley

    Professor George Perry

  758. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease

    Article • Journal of Neuroscience Research, March 2004, Wiley

    Professor George Perry

  759. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer’s disease

    Article • Acta Neuropathologica, February 2004, Springer Science + Business Media

    Professor George Perry

  760. Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid-β Precursor Protein and Amyloid-β Deposition

    Article • Journal of Biological Chemistry, February 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor George Perry

  761. Distribution, levels, and activation of MEK1 in Alzheimer's disease

    Article • Journal of Neurochemistry, February 2004, Wiley

    Professor George Perry

  762. Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients

    Article • Aging Cell, February 2004, Wiley

    Professor George Perry

  763. Oxidative Stress Mechanisms and Potential Therapeutic Modalities in Alzheimer Disease

    Article • Medicinal Chemistry Reviews - Online, January 2004, Bentham Science Publishers

    Professor George Perry

  764. Oxidative Stress in Alzheimer Disease: The Earliest Cytological and Biochemical Feature

    Article • January 2004, Karger Publishers

    Professor George Perry

  765. Nutritional Antioxidants, Vitamins, Cognition, and Neurodegenerative Disease

    Article • January 2004, Elsevier

    Professor George Perry

  766. Mechanisms Involved in Gender Differences in Alzheimer's Disease: The Role of Leuteinizing and Follicle Stimulating Hormones

    Article • January 2004, Elsevier

    Professor George Perry

  767. Editors' Summary

    Article • Brookings Papers on Economic Activity, January 2004, Project Muse

    Professor George Perry

  768. Copper Mediates Dityrosine Cross-Linking of Alzheimer's Amyloid-β †

    Article • Biochemistry, January 2004, American Chemical Society (ACS)

    Professor George Perry, Yoji Kato

  769. Amyloid-β-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression

    Article • Journal of Neurochemistry, December 2003, Wiley

    Professor George Perry

  770. Oxidative damage in the olfactory system in Alzheimer's disease

    Article • Acta Neuropathologica, December 2003, Springer Science + Business Media

    Professor George Perry

  771. Amyloids, Aggregates and Neuronal Inclusions: Good or Bad News for Neurons?

    Article • Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, December 2003, Bentham Science Publishers

    Professor George Perry

  772. La función del estrés oxidativo en la patogénesis de la enfermedad de Alzheimer

    Article • Revista chilena de neuro-psiquiatría, November 2003, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    Professor George Perry

  773. Oxidative Stress and Neuronal Adaptation in Alzheimer Disease: The Role of SAPK Pathways

    Article • Antioxidants & Redox Signaling, October 2003, Mary Ann Liebert Inc

    Professor George Perry

  774. Metal Homeostasis and Its Relation to Oxidative Stress in Alzheimer’s Disease

    Article • September 2003, Taylor & Francis

    Professor George Perry

  775. Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply

    Article • Brain Research Reviews, September 2003, Elsevier

    Professor George Perry

  776. Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β

    Article • Brain Research Reviews, September 2003, Elsevier

    Professor George Perry

  777. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice

    Article • Neurological Research, September 2003, Taylor & Francis

    Professor George Perry

  778. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease

    Article • Journal of Neurochemistry, August 2003, Wiley

    Professor George Perry

  779. Possible involvement of Wiskott–Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease

    Article • Neuroscience Letters, August 2003, Elsevier

    Professor George Perry

  780. Hydroxynonenal, toxic carbonyls, and Alzheimer disease

    Article • Molecular Aspects of Medicine, August 2003, Elsevier

    Professor George Perry

  781. Functional Implications of Antiestrogen Induction of Quinone Reductase: Inhibition of Estrogen-Induced Deoxyribonucleic Acid Damage

    Article • Molecular Endocrinology, July 2003, Endocrine Society

    Professor George Perry

  782. Amyotrophic lateral sclerosis: a novel hypothesis involving a gained 'loss of function' in the JNK/SAPK pathway

    Article • Redox Report, June 2003, Taylor & Francis

    Professor George Perry

  783. 4-Hydroxynonenal contributes to NGF withdrawal-induced neuronal apoptosis

    Article • Journal of Neurochemistry, April 2003, Wiley

    Professor George Perry

  784. Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants

    Article • Free Radical Biology and Medicine, April 2003, Elsevier

    Professor George Perry

  785. Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out?

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2003, Elsevier

    Professor George Perry

  786. Oxidative stress and predominant Aβ42(43) deposition in myopathies with rimmed vacuoles

    Article • Acta Neuropathologica, March 2003, Springer Science + Business Media

    Professor George Perry

  787. Metal Binding and Oxidation of Amyloid-β within Isolated Senile Plaque Cores:  Raman Microscopic Evidence †

    Article • Biochemistry, March 2003, American Chemical Society (ACS)

    Professor George Perry

  788. JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease

    Article • Journal of Neurochemistry, February 2003, Wiley

    Professor George Perry

  789. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?

    Article • Acta Neuropathologica, February 2003, Springer Science + Business Media

    Professor George Perry

  790. Role of high mobility group protein-1 (HMG1) in amyloid-β homeostasis

    Article • Biochemical and Biophysical Research Communications, February 2003, Elsevier

    Professor George Perry

  791. Signal Transduction in Alzheimer's Disease

    Article • January 2003, Karger Publishers

    Professor George Perry

  792. Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease

    Article • Journal of Biomedicine and Biotechnology, January 2003, Hindawi Publishing Corporation

    Professor George Perry

  793. Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells

    Article • Journal of Neuroscience Research, December 2002, Wiley

    Professor George Perry

  794. Role of the antioxidant ascorbate in hibernation and warming from hibernation

    Article • Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology, December 2002, Elsevier

    Professor George Perry

  795. Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response

    Article • Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology, December 2002, Elsevier

    Professor George Perry

  796. Induction of Heme Oxygenase-1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease

    Article • Journal of Neurochemistry, November 2002, Wiley

    Professor George Perry

  797. Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

    Article • Journal of Neurochemistry, November 2002, Wiley

    Professor George Perry

  798. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies

    Article • Neuroreport, November 2002, Wolters Kluwer Health

    Professor George Perry

  799. Atherosclerotic Lesions and Mitochondria DNA Deletions in Brain Microvessels as a Central Target for the Development of Human AD and AD-Like Pathology in Aged Transgenic Mice

    Article • Annals of the New York Academy of Sciences, November 2002, Wiley

    Professor George Perry

  800. Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain

    Article • Free Radical Biology and Medicine, November 2002, Elsevier

    Professor George Perry

  801. Amyloid-β: a (life) preserver for the brain

    Article • Neurobiology of Aging, November 2002, Elsevier

    Professor George Perry

  802. Amyloid-?: A vascular sealant that protects against hemorrhage?

    Article • Journal of Neuroscience Research, October 2002, Wiley

    Professor George Perry

  803. Role of mitochondrial dysfunction in Alzheimer's disease

    Article • Journal of Neuroscience Research, October 2002, Wiley

    Professor George Perry

  804. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology

    Article • Journal of Neuroscience Research, October 2002, Wiley

    Professor George Perry

  805. Mitochondrial Abnormalities and Oxidative Imbalance in Neurodegenerative Disease

    Article • Science of Aging Knowledge Environment, October 2002, American Association for the Advancement of Science

    Professor George Perry

  806. Book Review: Is Alzheimer’s Disease a Mitochondrial Disorder?

    Article • The Neuroscientist, October 2002, SAGE Publications

    Professor George Perry

  807. Lipid peroxidation in aging brain and Alzheimer’s disease1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers ma...

    Article • Free Radical Biology and Medicine, September 2002, Elsevier

    Professor George Perry

  808. Therapeutic Potential in Alzheimer Disease

    Article • Current Medicinal Chemistry, September 2002, Bentham Science Publishers

    Professor George Perry

  809. Oxidative Stress Increases Expression and Activity of BACE in NT2 Neurons

    Article • Neurobiology of Disease, August 2002, Elsevier

    Professor George Perry

  810. Ill-fated amyloid-? vaccine

    Article • Journal of Neuroscience Research, July 2002, Wiley

    Professor George Perry

  811. Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins

    Article • Peptides, July 2002, Elsevier

    Professor George Perry

  812. Possible mechanisms of APP-mediated oxidative stress in Alzheimer’s disease1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full...

    Article • Free Radical Biology and Medicine, July 2002, Elsevier

    Professor George Perry

  813. Metals and oxidative homeostasis in Alzheimer's disease

    Article • Drug Development Research, July 2002, Wiley

    Professor George Perry

  814. Cholesterol, oxidative stress, and Alzheimer’s disease: expanding the horizons of pathogenesis1 1This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found o...

    Article • Free Radical Biology and Medicine, July 2002, Elsevier

    Professor George Perry

  815. The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease

    Article • Peptides, July 2002, Elsevier

    Professor George Perry

  816. Causes and consequences of oxidative stress in Alzheimer’s disease 1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full lis...

    Article • Free Radical Biology and Medicine, June 2002, Elsevier

    Professor George Perry

  817. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s diseases1,2 11Guest Editors: Mark A. Smith and George Perry 22This article is part of a series of reviews on “Causes and Consequences of Oxid...

    Article • Free Radical Biology and Medicine, June 2002, Elsevier

    Professor George Perry

  818. Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a s...

    Article • Free Radical Biology and Medicine, June 2002, Elsevier

    Professor George Perry

  819. Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer’s disease1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is a part of a series of reviews on “Causes and Consequences of Oxidative Stre...

    Article • Free Radical Biology and Medicine, June 2002, Elsevier

    Professor George Perry

  820. Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease1,2 1This article is part of a series of reviews on “Causes and Consequences of Oxidative S...

    Article • Free Radical Biology and Medicine, June 2002, Elsevier

    Professor George Perry

  821. Decreased activity of the antioxidant heme oxygenase enzyme: implications in ischemia and in Alzheimer’s disease1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Str...

    Article • Free Radical Biology and Medicine, June 2002, Elsevier

    Professor George Perry, Sylvain Dore

  822. Apolipoprotein E isoform mediated regulation of nitric oxide release1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list o...

    Article • Free Radical Biology and Medicine, June 2002, Elsevier

    Professor George Perry, Dr. Candice Brown

  823. Dangers of the amyloid-β vaccination

    Article • Acta Neuropathologica, May 2002, Springer Science + Business Media

    Professor George Perry

  824. Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

    Article • Neurochemistry International, May 2002, Elsevier

    Professor George Perry

  825. Oxidative Damage to Nucleic Acids in Human Prion Disease

    Article • Neurobiology of Disease, April 2002, Elsevier

    Professor George Perry, Prof. Herbert Budka

  826. Microglial activation and amyloid-β clearance induced by exogenous heat-shock proteins

    Article • The FASEB Journal, April 2002, Federation of American Societies For Experimental Biology (FASEB)

    Professor George Perry

  827. The “Down's” Side of Mitochondria

    Article • Developmental Cell, March 2002, Elsevier

    Professor George Perry

  828. Systemic Increase of Oxidative Nucleic Acid Damage in Parkinson's Disease and Multiple System Atrophy

    Article • Neurobiology of Disease, March 2002, Elsevier

    Professor George Perry

  829. Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicity

    Article • International Journal of Circumpolar Health, March 2002, Co-Action Publishing

    Professor George Perry

  830. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans

    Article • Neuroscience Letters, February 2002, Elsevier

    Professor George Perry

  831. Alzheimer Disease and Oxidative Stress

    Article • Journal of Biomedicine and Biotechnology, January 2002, Hindawi Publishing Corporation

    Professor George Perry

  832. The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders

    Article • CNS Drugs, January 2002, Springer Science + Business Media

    Professor George Perry

  833. Signal Transduction in Alzheimer’s Disease

    Article • Neurosignals, January 2002, Karger Publishers

    Professor George Perry

  834. Role of Heme Catabolism in Neurodegenerative Diseases

    Article • January 2002, Springer Science + Business Media

    Professor George Perry

  835. Neuronal Survival and Death in Alzheimer Disease

    Article • January 2002, Springer Science + Business Media

    Professor George Perry

  836. Iron: A Pathological Mediator of Alzheimer Disease?

    Article • Developmental Neuroscience, January 2002, Karger Publishers

    Professor George Perry

  837. Involvement of maillard reactions in Alzheimer disease

    Article • Neurotoxicity Research, January 2002, Springer Science + Business Media

    Professor George Perry

  838. Differential Regulation of Glutamate Receptors in Alzheimer’s Disease

    Article • Neurosignals, January 2002, Karger Publishers

    Professor George Perry

  839. In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

    Article • Journal of Neurochemistry, December 2001, Wiley

    Professor George Perry

  840. High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal

    Article • Journal of Biological Chemistry, December 2001, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor George Perry

  841. Atherosclerotic Lesions Are Associated with Increased Immunoreactivity for Inducible Nitric Oxide Synthase and Endothelin-1 in Thoracic Aortic Intimal Cells of Hyperlipidemic Watanabe Rabbits

    Article • Experimental and Molecular Pathology, August 2001, Elsevier

    Professor George Perry

  842. Chemistry and Biochemistry of Oxidative Stress in Neurodegenerative Disease

    Article • Current Medicinal Chemistry, June 2001, Bentham Science Publishers

    Professor George Perry

  843. Effect of the herbicide 4-CPA on human erythrocyte antioxidant enzymesin vitro

    Article • Redox Report, June 2001, Taylor & Francis

    Professor George Perry

  844. Abortive apoptosis in Alzheimer's disease

    Article • Acta Neuropathologica, April 2001, Springer Science + Business Media

    Professor George Perry

  845. Forward

    Article • Journal of Alzheimer’s Disease, March 2001, IOS Press

    Professor George Perry

  846. Erythrocyte, plasma, and serum antioxidant activities in untreated toxic multinodular goiter patients

    Article • Free Radical Biology and Medicine, March 2001, Elsevier

    Professor George Perry

  847. Redox-active iron mediates amyloid-β toxicity

    Article • Free Radical Biology and Medicine, February 2001, Elsevier

    Professor George Perry

  848. Hibernation, a Model of Neuroprotection

    Article • The Scientific World JOURNAL, January 2001, Hindawi Publishing Corporation

    Professor George Perry

  849. Do Neurons Have a Choice in Death?

    Article • American Journal Of Pathology, January 2001, Elsevier

    Professor George Perry

  850. Protein Disulfide Isomerase in Alzheimer Disease

    Article • Antioxidants & Redox Signaling, September 2000, Mary Ann Liebert Inc

    Professor George Perry

  851. Metabolic, Metallic, and Mitotic Sources of Oxidative Stress in Alzheimer Disease

    Article • Antioxidants & Redox Signaling, September 2000, Mary Ann Liebert Inc

    Professor George Perry

  852. Sequestration of iron by Lewy bodies in Parkinson's disease

    Article • Acta Neuropathologica, August 2000, Springer Science + Business Media

    Professor George Perry

  853. Oxidative damage in Alzheimer’s disease: the metabolic dimension

    Article • International Journal of Developmental Neuroscience, July 2000, Elsevier

    Professor George Perry

  854. Oxidative stress in Alzheimer’s disease

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, July 2000, Elsevier

    Professor George Perry

  855. Activation of NADPH Oxidase in Alzheimer's Disease Brains

    Article • Biochemical and Biophysical Research Communications, June 2000, Elsevier

    Professor George Perry

  856. Competitive regulation of aβredox activity by copper and zinc: Parallels in the pathogenetic mechanisms of Alzheimer's disease and familial amyotrophic lateral sclerosis

    Article • Neurobiology of Aging, May 2000, Elsevier

    Professor Math P Cuajungco, Professor George Perry

  857. Alzheimer's plaques re-created in a test tube: Further insights into the mechanism of amyloid plaque formation

    Article • Neurobiology of Aging, May 2000, Elsevier

    Professor George Perry

  858. Activation of P38 kinase links π phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease

    Article • Neurobiology of Aging, May 2000, Elsevier

    Professor George Perry

  859. Mitochondrial abnormalities in Alzheimer disease

    Article • Neurobiology of Aging, May 2000, Elsevier

    Professor George Perry

  860. Increased oxidative stress involving olfactory neurons in Alzheimer disease

    Article • Neurobiology of Aging, May 2000, Elsevier

    Professor George Perry

  861. Human amyloid-derived aßcontains tyrosine cross-linked oligomers

    Article • Neurobiology of Aging, May 2000, Elsevier

    Professor George Perry

  862. Evidence for a Novel Heme-Binding Protein, HasAh, in Alzheimer Disease

    Article • Antioxidants & Redox Signaling, March 2000, Mary Ann Liebert Inc

    Professor George Perry

  863. How important is oxidative damage? Lessons from Alzheimer’s disease

    Article • Free Radical Biology and Medicine, March 2000, Elsevier

    Professor George Perry

  864. Amyloid-β junkies

    Article • The Lancet, February 2000, Elsevier

    Professor George Perry

  865. Overexpression of Heme Oxygenase in Neuronal Cells, the Possible Interaction with Tau

    Article • Journal of Biological Chemistry, February 2000, Elsevier

    Professor George Perry

  866. Histochemical and Immunocytochemical Approaches to the Study of Oxidative Stress

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2000, De Gruyter

    Professor George Perry

  867. Methods in Molecular Medicine, Vol. 32 Alzheimer's Disease: Methods and Protocols

    Article • Journal of Molecular Neuroscience, January 2000, Springer Science + Business Media

    Professor George Perry

  868. Neurodegeneration Methods and Protocols Jean Harry Hugh A. Tilson

    Article • The Quarterly Review of Biology, December 1999, University of Chicago Press

    Professor George Perry

  869. Neuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome

    Article • Annals of the New York Academy of Sciences, November 1999, Wiley

    Professor George Perry

  870. Diet and Oxidative Stress: A Novel Synthesis of Epidemiological Data on Alzheimer's Disease*

    Article • Journal of Alzheimer’s Disease, July 1999, IOS Press

    Professor George Perry

  871. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?

    Article • Free Radical Biology and Medicine, June 1999, Elsevier

    Professor George Perry

  872. INDUCTION OF NAPH CYTOCHROME P450 REDUCTASE BY AMYLOID β PROTEIN

    Article • Journal of Neuropathology & Experimental Neurology, May 1999, Oxford University Press (OUP)

    Professor George Perry

  873. The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction

    Article • Neuroscience, March 1999, Elsevier

    Professor George Perry

  874. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease

    Article • Redox Report, February 1999, Taylor & Francis

    Professor George Perry

  875. Hypertension in Dialysis Patients

    Article • Mineral and Electrolyte Metabolism, January 1999, Karger Publishers

    Professor George Perry

  876. RNA Oxidation in Alzheimer and Parkinson Diseases

    Article • Journal of Anti-Aging Medicine, January 1999, Mary Ann Liebert Inc

    Professor George Perry

  877. [10] In situ methods for detection and localization of markers of oxidative stress: Application in neurodegenerative disorders

    Article • January 1999, Elsevier

    Professor George Perry

  878. What are the facts and artifacts of the pathogenensis and etiology of Alzheimer disease?

    Article • Journal of Chemical Neuroanatomy, December 1998, Elsevier

    Professor George Perry

  879. A suicide note from Alzheimer disease neurons?

    Article • Nature Medicine, August 1998, Nature

    Professor George Perry

  880. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease

    Article • Brain Research, April 1998, Elsevier

    Professor George Perry

  881. Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease

    Article • Experimental Neurology, February 1998, Elsevier

    Professor George Perry

  882. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease

    Article • Brain Research, January 1998, Elsevier

    Professor George Perry

  883. The Role of Oxidative Stress in the Pathological Sequelae of Alzheimer Disease

    Article • January 1998, Springer Science + Business Media

    Professor George Perry

  884. Neuronal Oxidative Stress is a Common Feature of Alzheimer’s and Parkinson’s Diseases

    Article • January 1998, Springer Science + Business Media

    Professor George Perry

  885. ADVANCED GLYCATION AND LIPID MODIFICATION OF ROSENTHAL FIBERS IN ALEXANDERʼS DISEASE

    Article • Journal of Neuropathology & Experimental Neurology, May 1997, Oxford University Press (OUP)

    Professor George Perry

  886. Letter to the Editor

    Article • Journal of Neuropathology & Experimental Neurology, February 1997, Oxford University Press (OUP)

    Professor George Perry

  887. Early contribution of oxidative glycation in Alzheimer disease

    Article • Neuroscience Letters, October 1996, Elsevier

    Professor George Perry

  888. Oxidative posttranslational modifications in Alzheimer disease

    Article • Molecular and Chemical Neuropathology, May 1996, Springer Science + Business Media

    Professor George Perry

  889. APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology

    Article • Neurobiology of Aging, March 1996, Elsevier

    Professor George Perry

  890. Trypsin interaction with the senile plaques of Alzheimer disease is mediated by β-protein precursor

    Article • Molecular and Chemical Neuropathology, February 1996, Springer Science + Business Media

    Professor George Perry

  891. Protein Modifications and Interactions in Alzheimer’s Disease

    Article • January 1996, Springer Science + Business Media

    Professor George Perry

  892. Glial Cell Extracellular Matrix in Alzheimer's Disease

    Article • December 1995, World Scientific Pub Co Pte Lt

    Professor George Perry

  893. Free radical damage, iron, and Alzheimer's disease

    Article • Journal of the Neurological Sciences, December 1995, Elsevier

    Professor George Perry

  894. Evidence for oxidative stress in Pick disease and corticobasal degeneration

    Article • Brain Research, October 1995, Elsevier

    Professor George Perry

  895. Amyloidosis, advanced glycation end products and Alzheimer disease

    Article • Neuroreport, August 1995, Wolters Kluwer Health

    Professor George Perry

  896. Reply

    Article • Trends in Neurosciences, August 1995, Elsevier

    Professor George Perry

  897. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide

    Article • Nature Medicine, July 1995, Springer Science + Business Media

    Professor George Perry

  898. Characterization of the association of phospholipase C-δ with Alzheimer neurofibrillary tangles

    Article • Brain Research, January 1995, Elsevier

    Professor George Perry

  899. Alzheimer disease: An imbalance of proteolytic regulation?

    Article • Medical Hypotheses, April 1994, Elsevier

    Professor George Perry

  900. β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth

    Article • Experimental Neurology, December 1993, Elsevier

    Professor George Perry

  901. Barrier properties of testis microvessels.

    Article • Proceedings of the National Academy of Sciences, December 1993, Proceedings of the National Academy of Sciences

    Professor George Perry

  902. The Amyloid Precursor Protein in Ischemic Brain Injury and Chronic Hypoperfusiona

    Article • Annals of the New York Academy of Sciences, September 1993, Wiley

    Professor George Perry

  903. Aberrant Phosphoinositide Metabolism in Alzheimer's Diseasea

    Article • Annals of the New York Academy of Sciences, September 1993, Wiley

    Professor George Perry

  904. α1-Trypsin Immunoreactivity in Alzheimer Disease

    Article • Biochemical and Biophysical Research Communications, June 1993, Elsevier

    Professor George Perry

  905. Chondroitin Sulfate Proteoglycans Are Associated with the Lesions of Alzheimer's Disease

    Article • Experimental Neurology, June 1993, Elsevier

    Professor George Perry

  906. Accumulation of the β amyloid precursor protein at sites of ischemic injury in rat brain

    Article • Neuroreport, February 1993, Wolters Kluwer Health

    Professor George Perry

  907. Corrigendum

    Article • Brain Research, January 1993, Elsevier

    Professor George Perry

  908. Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases

    Article • Brain Research, May 1992, Elsevier

    Professor George Perry

  909. The Neuronal Cytoskeleton

    Article • Neurology, May 1992, Wolters Kluwer Health

    Professor George Perry

  910. α1-Antitrypsin and α1-antichymotrypsin are in the lesions of Alzheimerʼs disease

    Article • Neuroreport, February 1992, Wolters Kluwer Health

    Professor George Perry

  911. Dementia with argyrophilic grains

    Article • Annals of Neurology, December 1991, Wiley

    Professor George Perry

  912. Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease.

    Article • Journal of Histochemistry & Cytochemistry, July 1991, SAGE Publications

    Professor George Perry

  913. Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology

    Article • Brain Research, February 1991, Elsevier

    Professor George Perry

  914. Role of cytokeratin intermediate filaments in transhepatic transport and canalicular secretion

    Article • Hepatology, March 1990, Wiley

    Professor George Perry

  915. Tau-reactive neurofibrillary tangles in cerebellar cortex from patients with Alzheimer's disease

    Article • Neuroscience Letters, September 1989, Elsevier

    Professor George Perry

  916. Immunochemical Properties of Ubiquitin Conjugates in the Paired Helical Filaments of Alzheimer Disease

    Article • Journal of Neurochemistry, May 1989, Wiley

    Professor George Perry

  917. Phosphorylation of Neurofilaments Is Altered in Amyotrophic Lateral Sclerosis

    Article • Journal of Neuropathology & Experimental Neurology, November 1988, Oxford University Press (OUP)

    Professor George Perry

  918. AMYLOID PRECURSOR PROTEIN IN SENILE PLAQUES OF ALZHEIMER DISEASE

    Article • The Lancet, September 1988, Elsevier

    Professor George Perry

  919. Alterations in the Neuronal Cytoskeleton in Alzheimer Disease

    Article • January 1988, Springer Science + Business Media

    Professor George Perry

  920. Hirano bodies contain tau protein

    Article • Brain Research, February 1987, Elsevier

    Professor George Perry

  921. Ubiquitin in Alzheimer and other Neurodegenerative Diseases

    Article • January 1987, Springer Science + Business Media

    Professor George Perry

  922. Microfilament Involvement in Hirano Body Formation

    Article • January 1987, Springer Science + Business Media

    Professor George Perry

  923. Coexistence of cytokeratin, vimentin and neurofilament protein in human choroid plexus

    Article • January 1987, Springer Science + Business Media

    Professor George Perry

  924. Alteration of the Neurofilament-Microtubule Network in Alzheimer Disease and Other Neurodegenerative Disorders

    Article • January 1987, Springer Science + Business Media

    Professor George Perry

  925. Fertilization stimulates lipid peroxidation in the sea urchin egg

    Article • Developmental Biology, January 1985, Elsevier

    Professor George Perry

  926. Interaction of Calcium-Calmodulin in Microtubule Assembly in Vitro

    Article • January 1982, Springer Science + Business Media

    Professor George Perry

  927. Ca2+-stimulated production of H2O2 from naphthoquinone oxidation in Arbacia eggs

    Article • Experimental Cell Research, July 1981, Elsevier

    Professor George Perry

  928. Faculty of 1000 evaluation for Heme Binding Induces Dimerization and Nitration of Truncated β-Amyloid Peptide Aβ16 Under Oxidative Stress.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  929. Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease

    Article • Springer Science + Business Media

    Professor George Perry

  930. Role of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases

    Article • Springer Science + Business Media

    Professor George Perry

  931. The Changing landscape of Alzheimer’s disease: From Insoluble to Soluble and from Pathogen to Protector

    Article • Springer Science + Business Media

    Professor George Perry

  932. Neurogenesis in Alzheimer’s Disease

    Article • Springer Science + Business Media

    Professor George Perry

  933. Mechanisms of DNA Damage and Repair in Alzheimer Disease

    Article • Springer Science + Business Media

    Professor George Perry

  934. Cell Cycle Activation and the Amyloid-β Protein in Alzheimer’s Disease

    Article • Springer Science + Business Media

    Professor George Perry

  935. Neuroinflammatory Environments Promote Amyloid-β Deposition and Posttranslational Modification

    Article • Springer Science + Business Media

    Professor George Perry

  936. Apoptotic and Oxidative Indicators in Alzheimer's Disease

    Article • Springer Science + Business Media

    Professor George Perry

  937. Phosphorylation, Microtubule Binding and Aggregation of Tau Protein in Alzheimer's Disease

    Article • Wiley

    Professor George Perry

  938. Oxidative Damage and Antioxidant Responses in Alzheimer's Disease

    Article • Wiley

    Professor George Perry

  939. Neuroinflammatory Responses in the Alzheimer's Disease Brain Promote the Oxidative Post-translational Modification of Amyloid Deposits

    Article • Wiley

    Professor George Perry

  940. Involvement of gonadotropins in cognitive function: implications for Alzheimer's disease

    Article • Cambridge University Press

    Professor George Perry

  941. Faculty of 1000 evaluation for Vascular smooth muscle actin is reduced in Alzheimer disease brain: a quantitative analysis.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  942. Faculty of 1000 evaluation for The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  943. Faculty of 1000 evaluation for The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivo.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  944. Faculty of 1000 evaluation for Testing the amyloid toxicity hypothesis of Alzheimer's disease in transgenic Caenorhabditis elegans model.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  945. Faculty of 1000 evaluation for Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  946. Faculty of 1000 evaluation for Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patients.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  947. Faculty of 1000 evaluation for Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  948. Faculty of 1000 evaluation for Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  949. Faculty of 1000 evaluation for Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  950. Faculty of 1000 evaluation for Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  951. Faculty of 1000 evaluation for Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  952. Faculty of 1000 evaluation for Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  953. Faculty of 1000 evaluation for Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  954. Faculty of 1000 evaluation for Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  955. Faculty of 1000 evaluation for Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  956. Faculty of 1000 evaluation for Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  957. Faculty of 1000 evaluation for Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  958. Faculty of 1000 evaluation for Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  959. Faculty of 1000 evaluation for Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  960. Faculty of 1000 evaluation for How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for beta-amyloid fibrils.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  961. Faculty of 1000 evaluation for Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  962. Faculty of 1000 evaluation for Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  963. Faculty of 1000 evaluation for Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  964. Faculty of 1000 evaluation for Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease?

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  965. Faculty of 1000 evaluation for Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  966. Faculty of 1000 evaluation for Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  967. Faculty of 1000 evaluation for Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  968. Faculty of 1000 evaluation for Deficiency of the copper chaperone for superoxide dismutase increases amyloid-β production.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  969. Faculty of 1000 evaluation for Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  970. Faculty of 1000 evaluation for Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  971. Faculty of 1000 evaluation for Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  972. Faculty of 1000 evaluation for Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Abeta deposition, in an AbetaPP/PS double transgenic mouse model of Alzheimer's disease.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  973. Faculty of 1000 evaluation for Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  974. Faculty of 1000 evaluation for Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  975. Faculty of 1000 evaluation for Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  976. Faculty of 1000 evaluation for Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  977. Faculty of 1000 evaluation for ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  978. Faculty of 1000 evaluation for alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  979. Faculty of 1000 evaluation for Alpha-synuclein has structural and functional similarities to small heat shock proteins.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  980. Faculty of 1000 evaluation for Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  981. Faculty of 1000 evaluation for Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  982. Faculty of 1000 evaluation for Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  983. Faculty of 1000 evaluation for A new function of microtubule-associated protein tau: involvement in chromosome stability.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  984. Faculty of 1000 evaluation for A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease.

    Article • Faculty of 1000, Ltd.

    Professor George Perry

  985. Alternative approaches to Alzheimer's Disease

    Article • ScienceOpen

    Professor George Perry